Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1050.Time spend outdoors in summer,49076,0.0341471578593014,0.0120021665171586,0.0106229114856705,0.0576714042329323,0.00444356430309776
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1060.Time spent outdoors in winter,45316,0.0325812222425933,0.0136569250948581,0.0058136490566713,0.0593487954285152,0.0170556257533348
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X1070.Time spent watching television (TV),50261,0.0163620787143045,0.0118332186210397,-0.00683102978293321,0.0395551872115423,0.166761119210454
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X1080.Time spent using computer,45250,-0.0140273096171273,0.0128412966858862,-0.0391962511214643,0.0111416318872098,0.274687516656944
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X1090.Time spent driving,44113,0.00739202322401287,0.0133697056309819,-0.0188125998127117,0.0335966462607374,0.580342447095275
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1160.Sleep duration,52069,0.000710166991586669,0.0111403241743453,-0.0211248683901301,0.0225452023733034,0.949171792676649
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,34554,0.0507339535031841,0.0312596874133437,-0.0105350338269696,0.112002940833338,0.104622430751645
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,34554,0.0263973305198436,0.0307460327246124,-0.0338648936203966,0.0866595546600839,0.390602258160429
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,34554,-0.0475366240912105,0.0361440100559804,-0.118378883800932,0.023305635618511,0.188470689039391
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,34554,-0.00930561533242079,0.0376092143104816,-0.0830196753809648,0.0644084447161232,0.804580879250264
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,34554,-0.0170343079040744,0.0386138097218645,-0.0927173749589288,0.0586487591507801,0.659116593081271
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,34554,-0.103223041445083,0.0742890174120428,-0.248829515572687,0.0423834326825205,0.164716021463342
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,34554,0.0952720103655393,0.0765001305663758,-0.0546682455445574,0.245212266275636,0.213018053928769
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,34554,0.0179707359196971,0.0542278455375385,-0.0883158413338785,0.124257313173273,0.740354040727465
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,34554,-0.00729060775457401,0.0398861272135997,-0.0854674170932294,0.0708862015840814,0.854969750883961
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,34554,-0.0185132160376172,0.027987301762892,-0.0733683274928856,0.0363418954176511,0.50831476419899
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,34554,0.0566590139578868,0.0394777353098943,-0.020717347249506,0.13403537516528,0.151255258527974
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,34554,0.00229984185149963,0.0227630471690213,-0.0423157305997821,0.0469154143027814,0.919525359219364
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,34554,0.0140791877055383,0.0291251323419116,-0.0430060716846084,0.0711644470956851,0.62881923868214
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,34554,0.061064657188927,0.0443553163500694,-0.0258717628572091,0.148001077235063,0.168629005925128
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,34554,0.0499238495477332,0.0418276595421571,-0.0320583631548947,0.131906062250361,0.2326763414423
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,34554,0.00661875990046194,0.0515995429347709,-0.0945163442516891,0.107753864052613,0.897936390479974
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,34554,0.0460701101788829,0.0485918059584971,-0.0491698294997715,0.141310049857537,0.343097678330447
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,34554,-0.0305585564242248,0.0326215208647636,-0.0944967373191614,0.0333796244707119,0.348902855169506
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,34554,-0.00980679893829858,0.0309711869723837,-0.0705103254041706,0.0508967275275735,0.751520944821662
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,34554,0.00697710329273046,0.0381986709639523,-0.0678922917966161,0.081846498382077,0.855073728468238
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120040.Fatigue severity over the past week,34562,0.0146804369601276,0.0186135181201871,-0.0218020585554392,0.0511629324756943,0.430306248143433
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120041.Waking unrefreshed severity over the past week,34564,0.0110144403605745,0.0183440479100805,-0.0249398935431832,0.0469687742643322,0.548227921714747
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120042.Cognitive symptoms severity over the past week,34562,-0.00747600803648914,0.0202766489268868,-0.0472182399331872,0.0322662238602089,0.712358364765717
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120098.Mobility problems today,34567,-0.00872156426447814,0.0229035195786793,-0.0536124626386896,0.0361693341097334,0.703362326253817
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120099.Self-care problems today,34567,-0.0687527600364208,0.0355529950528417,-0.13843663033999,0.000931110267148941,0.0531627447120101
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120100.Problems doing usual activities,34567,0.0191474891566962,0.0214961644927495,-0.0229849932490928,0.0612799715624851,0.373088800502193
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120101.Pain or discomfort today,34567,-0.00222682411891168,0.0186413337849961,-0.038763838337504,0.0343101900996807,0.90491612867666
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120102.Anxiety or depression today,34567,0.0128388351166666,0.0221426644709945,-0.0305607872464826,0.0562384574798157,0.562045915885363
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120103.Scale to indicate how health is today,34533,-0.000168142248173426,0.00986162983926252,-0.019496936733128,0.0191606522367811,0.986396927962945
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,34551,-0.0131208898772534,0.0221756181114031,-0.0565851013756035,0.0303433216210967,0.554076796128871
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",34535,0.0242763855640503,0.0226664873554086,-0.0201499296525505,0.0687027007806512,0.284182190145181
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",34556,0.018825469576708,0.0183392958340281,-0.017119550257987,0.0547704894114031,0.304674495702609
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,34556,0.0165686226353731,0.0187407242393151,-0.0201631968736845,0.0533004421444308,0.3766635968219
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,34553,-0.0274541550210802,0.0231003537963687,-0.0727308484619629,0.0178225384198025,0.23467336957465
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120109.Feeling bad about self over the last two weeks,34526,0.0251378603402541,0.0235286429375558,-0.0209782798173552,0.0712540004978635,0.285367017797125
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120110.Trouble concentrating over the last two weeks,34558,-0.0126375516454484,0.0236918393094749,-0.0590735566920192,0.0337984534011224,0.593758320070099
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,34542,-0.0312732015013173,0.0354439337300824,-0.100743311612279,0.0381969086096443,0.377618915164738
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,34491,0.00981895370572453,0.0461447472654783,-0.0806247509346128,0.100262658346062,0.831498006697946
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",31520,-0.0276005926084407,0.0246640562684155,-0.0759421428945351,0.0207409576776538,0.263149057472898
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,48985,0.0344878726263881,0.0266081510575351,-0.0176641034463807,0.0866398486991568,0.194939373141475
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,47688,0.0319349184407851,0.0161389266926917,0.000302622123109386,0.0635672147584608,0.0478555359787688
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X1289.Cooked vegetable intake,51031,-0.0079671973698165,0.0114985422493206,-0.030504340178485,0.014569945438852,0.488386012795472
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,50496,-0.031013254405563,0.0123338047941713,-0.0551875118021387,-0.00683899700898723,0.0119262412036961
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X1309.Fresh fruit intake,51027,-0.0232369605740871,0.0122325091047897,-0.0472126784194748,0.000738757271300683,0.057495286407538
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X1319.Dried fruit intake,49472,-0.0282091165485151,0.0128674057107757,-0.0534292317416356,-0.00298900135539461,0.0283673620454136
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X134.Number of self-reported cancers,52301,-0.0240240785003757,0.0254710173500445,-0.0739472725064629,0.0258991155057116,0.345590341683554
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X135.Number of self-reported non-cancer illnesses,52301,0.0392800971461589,0.0111754097100875,0.0173762941143875,0.0611839001779304,0.000440655458290012
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X136.Number of operations, self-reported",52301,0.00091288722392192,0.0111893026970891,-0.0210181460623726,0.0228439205102165,0.934976737942459
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X137.Number of treatments or medications taken,52301,0.0264656780853118,0.0111422524770657,0.00462686323026296,0.0483044929403606,0.0175434746008048
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X1438.Bread intake,51429,-0.00583070966056949,0.00624461887031391,-0.0180701626463847,0.00640874332524577,0.350457834418454
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X1458.Cereal intake,50659,-0.014160889879443,0.011563718939943,-0.0368257790017313,0.00850399924284524,0.220738047450369
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X1488.Tea intake,51203,-0.00824915613512582,0.00590221915843576,-0.0198175056856599,0.00331919341540826,0.162233631014868
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X1498.Coffee intake,49940,-0.00139408996125368,0.0116151973297879,-0.024159876727638,0.0213716968051307,0.904465912041577
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X1528.Water intake,50282,-0.00395189276112265,0.0118756170150448,-0.0272281021106105,0.0193243165883651,0.739307768512114
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1568.Average weekly red wine intake,43176,-0.0252330688185829,0.0134256619969897,-0.0515473663326828,0.00108122869551705,0.0601959990686741
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,43169,-0.00657373449356555,0.0137542572527841,-0.0335320787090224,0.0203846097218913,0.632697038799668
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1588.Average weekly beer plus cider intake,43221,0.00808021132077656,0.0150794634978884,-0.0214755371350847,0.0376359597766378,0.59207384198759
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1598.Average weekly spirits intake,43142,0.0288040103022682,0.0151292871153144,-0.00084939244374807,0.0584574130482845,0.0569435873435193
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1608.Average weekly fortified wine intake,43210,0.0309815991194463,0.0274991702104506,-0.0229167744930369,0.0848799727319295,0.259909707404307
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1737.Childhood sunburn occasions,45738,-0.0134748631894516,0.0134505164861284,-0.0398378755022634,0.0128881491233601,0.316446401386573
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X1807.Father's age at death,40826,0.00456444695666027,0.00834989044121143,-0.0118013383081141,0.0209302322214347,0.584628099756248
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X1845.Mother's age,40075,0.0182937672995475,0.0127164650210523,-0.00663050414171497,0.0432180387408099,0.150286292047116
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X1873.Number of full brothers,51796,0.00379089977034488,0.0111779679352689,-0.0181179173827823,0.025699716923472,0.734506564706536
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X1883.Number of full sisters,51798,0.00624260522373536,0.0111980762928684,-0.0157056243102868,0.0281908347577575,0.5772099855066
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X20015.Sitting height,52065,-0.0344853639598979,0.00791332617731366,-0.0499954832674326,-0.0189752446523631,1.31789301774154e-05
PLA2G4A,Cytosolic phospholipase A2,Cognitive function,X20016.Fluid intelligence score,32819,-0.00196208678281701,0.0193057413006596,-0.0398013397321099,0.0358771661664758,0.919050822412099
PLA2G4A,Cytosolic phospholipase A2,Cognitive function,X20018.Prospective memory result,33146,-0.0414652452587566,0.0278554460789889,-0.0960619195735749,0.0131314290560618,0.136630209990342
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),32726,0.00973970624380465,0.0107321204117952,-0.011295249763314,0.0307746622509233,0.364151996289295
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),32719,-0.00520814245375188,0.0106574321365902,-0.0260967094414686,0.0156804245339649,0.625075809759306
PLA2G4A,Cytosolic phospholipase A2,Cognitive function,X20023.Mean time to correctly identify matches,51985,0.00470479575740665,0.00627227148744342,-0.00758885635798245,0.0169984478727958,0.453204122802661
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#1.Illnesses of father_Heart disease,49026,0.00661109274604132,0.0136277162421467,-0.0200992310885662,0.0333214165806488,0.627594665597217
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,48606,-0.0218068391123403,0.0309271670678904,-0.0824240865654055,0.038810408340725,0.480752759455167
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,48570,0.0208930771495277,0.0415683826799787,-0.0605809529032305,0.102367107202286,0.615236339421177
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#12.Illnesses of father_Severe depression,48602,0.0341710099892193,0.0318246807197401,-0.0282053642214714,0.0965473841999099,0.282955654239079
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,48604,0.0312717798289318,0.0232011492558834,-0.0142024727125997,0.0767460323704633,0.177717435594665
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#2.Illnesses of father_Stroke,48766,0.00386598562022594,0.0179094508950159,-0.0312365381340052,0.0389685093744571,0.829096401383683
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,48704,-0.0179008197391272,0.0232538333161164,-0.0634783330387154,0.0276766935604609,0.441425377846019
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,48605,-0.0754075503606776,0.0280031060203638,-0.130293638160591,-0.0205214625607646,0.00708964978444624
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,48729,0.00489535400162974,0.02219697425645,-0.0386107155410122,0.0484014235442717,0.825451265841632
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,48884,0.0233458963971133,0.0140672203280433,-0.00422585544585158,0.0509176482400781,0.0970083726767071
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#9.Illnesses of father_Diabetes,48732,-0.0102781003155976,0.0192467500399664,-0.0480017303939317,0.0274455297627364,0.593334235998782
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,50096,0.013468678857291,0.016321626821444,-0.0185217097127393,0.0454590674273213,0.409263038247747
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,49967,0.0646922875258876,0.0264142683776761,0.0129203215056425,0.116464253546133,0.0143262341128004
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,49912,-0.0345638189759239,0.0554988668543645,-0.143341598010478,0.0742139600586305,0.533431775048939
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,49957,0.0375551932915693,0.0237800550147208,-0.00905371453728353,0.0841641011204222,0.114285625143087
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#2.Illnesses of mother_Stroke,50041,0.0166166528622637,0.0193230289219592,-0.0212564838247763,0.0544897895493036,0.389829781384373
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,49965,-0.0177895585530019,0.031506004477104,-0.0795413273281258,0.0439622102221219,0.572323327202104
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,49943,-0.0266527525803523,0.0298846391315202,-0.0852266452781318,0.0319211401174272,0.37247910428695
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,49977,-0.00130148983633095,0.0226248866377255,-0.0456462676462729,0.043043287973611,0.954127670298737
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,49980,-0.00654962739199903,0.0265693456665932,-0.0586255448985217,0.0455262901145237,0.805288877395035
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,50194,0.0101537633186529,0.0128181491016242,-0.0149698089205306,0.0352773355578364,0.428286425954569
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,50033,0.0180737934420741,0.0198685167216393,-0.020868499332339,0.0570160862164872,0.363004951110638
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,47209,0.00516226879738449,0.0260646056307607,-0.0459243582389064,0.0562488958336754,0.843002455735609
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,47092,0.220903863775228,0.147964064186232,-0.0691057020297867,0.510913429580243,0.135462237912469
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,47090,-0.286083791921664,0.127196066456445,-0.535388082176296,-0.0367795016670315,0.0245119024041309
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,47179,-0.0211583467365035,0.0239465368471501,-0.0680935589569177,0.0257768654839108,0.376939626988707
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,47097,0.0861195951084063,0.0805329759043606,-0.0717250376641406,0.243964227880953,0.284913826870529
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,47109,0.00438412795480974,0.0450152118096237,-0.0838456871920528,0.0926139431016723,0.922415823418304
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,47099,0.0513303430480026,0.061026634956593,-0.0682818614669197,0.170942547562925,0.400292855660683
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,47107,0.0510706053958644,0.0537562993081092,-0.0542917412480297,0.156432952039758,0.342102080702229
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,47111,-0.0194047689341973,0.0362816343010326,-0.0905167721642212,0.0517072342958267,0.592767528024524
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,47116,0.0234393517819089,0.0475358274981787,-0.0697308701145213,0.116609573678339,0.621954980893493
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,47301,0.0143754441495166,0.0167953235413844,-0.0185433899915967,0.0472942782906299,0.392051082516623
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,47191,0.02151177695369,0.0245855180738609,-0.0266758384710774,0.0696993923784574,0.381595115238093
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20127.Neuroticism score,46689,0.0128287468700095,0.0116447427667907,-0.00999494895290041,0.0356524426929193,0.27061368041436
PLA2G4A,Cytosolic phospholipase A2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,32819,0.00578562652557417,0.0196669585301078,-0.0327616121934371,0.0443328652445854,0.768627160290264
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X20161.Pack years of smoking,31731,0.01732629430736,0.0130300336310946,-0.00821257160958547,0.0428651602243054,0.183649126955787
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,31731,0.0181555539974981,0.0121817925215588,-0.00572075934475711,0.0420318673397533,0.13616325243832
PLA2G4A,Cytosolic phospholipase A2,Cognitive function,X20191.Fluid intelligence score,31433,0.0394235757350605,0.0204052007829408,-0.000570617799503452,0.0794177692696245,0.0533924191572988
PLA2G4A,Cytosolic phospholipase A2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,31433,0.0393862506646225,0.0209385333556832,-0.00165327471251654,0.0804257760417615,0.0600046653893255
PLA2G4A,Cytosolic phospholipase A2,Cognitive function,X20240.Maximum digits remembered correctly,30782,0.0297881865518523,0.0218610932562933,-0.0130595562304827,0.0726359293341872,0.173049226509094
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X20255.Spirometry QC measure,45139,0.0330528425182796,0.014936282014278,0.0037777297702946,0.0623279552662645,0.0269135237701007
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X20261.avMSE,29967,-0.0169697917856586,0.0132334282501547,-0.0429073111559618,0.00896772758464456,0.199771083798527
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X20262.Myopia diagnosis,29967,0.0199159298443703,0.0288030459081845,-0.0365380401356714,0.0763698998244119,0.489307689409652
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X20280.Glucose-lactate,39893,0.075948667548494,0.0080942216632082,0.060083993088606,0.0918133420083821,7.24753953671475e-21
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X20281.Spectrometer-corrected alanine,39927,0.0979606689483296,0.00797472334035877,0.0823302112012264,0.113591126695433,1.57930561131246e-34
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,32703,0.0191693615808609,0.0383158481512896,-0.0559297007956667,0.0942684239573885,0.616877355864079
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,32700,0.0957015011939941,0.076759296808385,-0.0547467205504405,0.246149722938429,0.212513382885496
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),32698,-0.126192819875652,0.0845241627639727,-0.291860178893038,0.0394745391417345,0.13547831830875
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),32698,0.0226569116200064,0.0369344929832197,-0.0497346946271042,0.095048517867117,0.539604519575442
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),32698,0.0228242945021138,0.0593965407891257,-0.0935929254445726,0.1392415144488,0.700787763266016
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,32705,0.0160010909621331,0.0772637214686575,-0.135435803116436,0.167437985040702,0.835938811269377
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,32705,-0.0231303449491963,0.0506922987958247,-0.122487250589013,0.07622656069062,0.648193282239368
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,32705,-0.0165866048504042,0.0554341535045001,-0.125237545719224,0.092064336018416,0.764784760694522
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,32705,-0.0714160529167895,0.0862492347260941,-0.240464552979934,0.0976324471463548,0.407681766136114
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,32705,-0.0242495974242254,0.100093268214854,-0.220432403125339,0.171933208276888,0.80857656458815
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,32705,0.0326337997883564,0.0567931182501539,-0.0786807119819453,0.143948311558658,0.565570819377864
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,32705,0.00599933538528188,0.0981884996519883,-0.186450123932615,0.198448794703179,0.951280803165435
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,32705,0.0480913421250021,0.0742934514111015,-0.0975238226407568,0.193706506890761,0.517444227268034
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),32708,0.127205472476635,0.0990854127356923,-0.0670019364853223,0.321412881438592,0.199246905097773
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),32708,0.00853109196296608,0.0492531736173337,-0.0880051283270079,0.10506731225294,0.862491127397137
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),32708,-0.0821309277921352,0.0680783752626996,-0.215564543307026,0.051302687722756,0.22768889497067
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,32708,0.114040924367856,0.111991064053432,-0.10546156117687,0.333543409912582,0.308561452982618
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20600.Liking for adding salt to foods,35455,-0.0152613181660239,0.0164891659658411,-0.0475800834590724,0.0170574471270246,0.354706397849897
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20601.Liking for aniseed,35455,-0.0137980544346794,0.0164838711571112,-0.0461064419026174,0.0185103330332587,0.402573883281588
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20602.Liking for apple juice,35455,0.0325993812179504,0.0165230771288597,0.000214150045385331,0.0649846123905154,0.0485237773604632
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20603.Liking for apples,35455,0.00889489356481041,0.0168514209613789,-0.0241338915194922,0.041923678649113,0.597618872126104
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20604.Liking for asparagus,35455,-0.0143284652453561,0.016714264683218,-0.0470884240244634,0.0184314935337513,0.39131911606162
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20605.Liking for aubergine,35455,-0.0411897369208654,0.0165662313142194,-0.0736595502967354,-0.00871992354499546,0.0129194443858237
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20606.Liking for avocados,35455,-0.0124717752379772,0.016701497986392,-0.0452067112913055,0.0202631608153512,0.455232106755967
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20607.Liking for bacon,35455,0.0102743193127954,0.0166382792422381,-0.0223367080019913,0.0428853466275822,0.536909909254245
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20608.Liking for baked or steamed fish,35455,-0.0128424504646202,0.0167525158452041,-0.0456773815212203,0.0199924805919798,0.443335995107918
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20609.Liking for bananas,35455,0.0120522207685692,0.0171112299182551,-0.0214857898712109,0.0455902314083493,0.481231685657321
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,35455,-0.0247962446582456,0.016626157657515,-0.057383513666975,0.00779102435048375,0.135883841711719
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20611.Liking for beef steak,35455,0.00647237916376279,0.0166297323275824,-0.0261218961982987,0.0390666545258243,0.697131471428831
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20612.Liking for beetroot,35455,-0.000692804567674033,0.0168070402078966,-0.0336346033751513,0.0322489942398032,0.967120348450406
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20613.Liking for bell pepper,35455,-0.0126998585861868,0.0167259319562502,-0.0454826852204372,0.0200829680480637,0.447693626305169
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20614.Liking for bicycling,35455,0.0105120711407477,0.0165078491330713,-0.0218433131600721,0.0428674554415674,0.524272726357228
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20615.Liking for biscuits,35455,0.0195125265884935,0.0166734831931613,-0.0131675004701027,0.0521925536470896,0.241915209570901
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20616.Liking for bitter foods,35455,-0.0193681872572419,0.0165242454710905,-0.0517557083805793,0.0130193338660954,0.241178116266159
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20617.Liking for bitter or ale,35455,-5.25291929431661e-05,0.0168286110751105,-0.0330366069001597,0.0329315485142733,0.997509523547342
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20618.Liking for black olives,35455,-0.0407802257924204,0.0165913232990537,-0.0732992194585655,-0.00826123212627518,0.0139887753355543
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20619.Liking for black pepper,35455,-0.00291841287386745,0.0167572687071592,-0.0357626595398995,0.0299258337921646,0.861744312946155
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20620.Liking for blue cheese,35455,0.0118132426792497,0.0165279376830691,-0.0205815151795657,0.0442080005380652,0.474781705009079
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20621.Liking for bolognese sauce,35455,0.000504780507331777,0.0166379889438892,-0.032105677822691,0.0331152388373545,0.975797189064756
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20622.Liking for broad beans,35455,-0.0163165442129967,0.0165267662904955,-0.0487090061423678,0.0160759177163744,0.32352605725783
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20623.Liking for broccoli,35455,-0.00473648431676926,0.0170784365815202,-0.0382102200165489,0.0287372513830103,0.781526211782861
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20624.Liking for brown rice,35455,-0.00105961382552835,0.0166022176172788,-0.0335999603553947,0.0314807327043381,0.949111762145047
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20625.Liking for brussel sprouts,35455,0.00428299023495594,0.0166777374253392,-0.0284053751187088,0.0369713555886207,0.797330913320822
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20626.Liking for burgers (meat),35455,0.00504687170461551,0.016584135402628,-0.0274580336845353,0.0375517770937664,0.760890143667856
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20627.Liking for burn of spicy foods,35455,-0.0210974383544933,0.0165718488786372,-0.0535782621566223,0.0113833854476357,0.203012008775259
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20628.Liking for butter on bread,35455,0.0320487379204444,0.0168020901786209,-0.000883358829652528,0.0649808346705413,0.0564901906936827
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20629.Liking for butternut squash,35455,-0.0371034690073829,0.0165936798264036,-0.0696270814671341,-0.00457985654763182,0.0253707312025035
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20630.Liking for cabbage,35455,-0.0100589543387124,0.0167783269022481,-0.0429444750671186,0.0228265663896938,0.548837431905181
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20631.Liking for cake,35455,0.0129131059317811,0.0166883498376657,-0.0197960597500437,0.045622271613606,0.43907688094633
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20632.Liking for cake icing,35455,0.00645914524334336,0.0164384930447335,-0.0257603011243342,0.0386785916110209,0.694379842390891
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20633.Liking for capers,35455,-0.0336239515954462,0.0164721235163744,-0.06590931368754,-0.00133858950335239,0.0412472094175235
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20634.Liking for cauliflower,35455,-0.000971424928933519,0.0168973092101462,-0.03409015098082,0.032147301122953,0.954155928119233
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20635.Liking for cereal or granola bar,35455,0.00552374957273442,0.0164819173322615,-0.0267808083984981,0.0378283075439669,0.7375255569342
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20636.Liking for cheesecake,35455,0.0328846091792654,0.0165711008883674,0.000405251438065392,0.0653639669204655,0.047228656825244
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20637.Liking for cherries,35455,-0.00539460784090039,0.0173019131392746,-0.0393063575938786,0.0285171419120778,0.755203786782415
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20638.Liking for chicken,35455,0.00387776984101496,0.0173436577084641,-0.0301157992675747,0.0378713389496046,0.82308471093295
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20639.Liking for chilli pepper,35455,-0.0277897438688825,0.0165799623194095,-0.0602864700149251,0.00470698227716007,0.0937447723196003
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20640.Liking for chips or french fries,35455,0.0147540825415051,0.016746868053071,-0.0180697788425139,0.0475779439255242,0.378333128517654
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20641.Liking for cigarette smoking,35455,-0.0238938413321325,0.0259573662967677,-0.0747702792737972,0.0269825966095322,0.357328974544085
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20642.Liking for cod,35455,0.0219828706016074,0.0169343280114087,-0.0112084123007535,0.0551741535039684,0.194270305242908
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20643.Liking for coffee with sugar,35455,-0.0103588731845723,0.0181263900299658,-0.0458865976433053,0.0251688512741607,0.567685256951141
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20644.Liking for coffee without sugar,35455,-0.0200528734520001,0.0168622427399375,-0.0531028692222775,0.0129971223182773,0.234378477618086
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20645.Liking for coriander,35455,-0.00439085292080612,0.0165518637802318,-0.0368325059300604,0.0280508000884482,0.790799676800758
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20646.Liking for corn flakes,35455,0.0212428254698307,0.0165364293783648,-0.0111685761117642,0.0536542270514257,0.198955069448324
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20647.Liking for cream,35455,0.00823476750382405,0.0165068444527516,-0.0241186476235691,0.0405881826312171,0.617880525780679
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20648.Liking for croissant,35455,0.00556748793264444,0.0165842107476643,-0.0269375651327776,0.0380725409980665,0.737095527235281
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20649.Liking for cucumber,35455,-0.00667811361468429,0.0166689928629851,-0.0393493396261351,0.0259931123967666,0.688699279285583
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20650.Liking for curry,35455,-0.0198616125226857,0.0168388430812689,-0.0528657449619727,0.0131425199166013,0.238218697451143
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20651.Liking for dairy products,35455,0.0265419361722096,0.0168067034179511,-0.00639920252697469,0.0594830748713938,0.114306709317203
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20652.Liking for dark chocolate,35455,-0.00604515342422748,0.0165931930200679,-0.0385678117435606,0.0264775048951057,0.715629254618253
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20653.Liking for diet fizzy drinks,35455,0.0165559960392384,0.016937073402083,-0.0166406678288443,0.0497526599073211,0.328341888718832
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20654.Liking for dried fruit,35455,-0.02778898138997,0.0166510182512223,-0.0604249771623657,0.00484701438242572,0.0951630630714026
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20655.Liking for eggs,35455,-0.0123007728974087,0.0170896934948741,-0.0457965721473619,0.0211950263525444,0.471676661965866
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20656.Liking for exercising alone,35455,0.0237237343048337,0.0164790814418678,-0.00857526532122712,0.0560227339308946,0.149999909742447
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20657.Liking for exercising with others,35455,0.0138965403357822,0.0165176529467023,-0.0184780594397544,0.0462711401113187,0.400189153256525
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20658.Liking for extra virgin olive oil,35455,-0.0127428535967181,0.0168930414280585,-0.0458532147957127,0.0203675076022765,0.450669065330464
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20659.Liking for fatty foods,35455,-0.0066879599117556,0.0164988271921026,-0.0390256612082767,0.0256497413847655,0.685220601906758
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20660.Liking for fresh tomatoes,35455,-0.00902028332374728,0.0176316844360722,-0.0435783848184489,0.0255378181709543,0.608944166951528
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20661.Liking for fried chicken,35455,0.00852140288665608,0.0164497500235698,-0.0237201071595408,0.040762912932853,0.604449821941267
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20662.Liking for fried or battered fish,35455,0.0161365562013609,0.0165780039984519,-0.0163563316356049,0.0486294440383266,0.330389031798949
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20663.Liking for fruit,35455,0.0195839107598905,0.0180907636841504,-0.0158739860610443,0.0550418075808252,0.279036765490681
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20664.Liking for garlic,35455,-0.013248880343334,0.0168914718621471,-0.0463561651931424,0.0198584045064744,0.432848915277097
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20665.Liking for gherkins,35455,-0.0293628992740327,0.0164515984143157,-0.0616080321660915,0.00288223361802598,0.0743190663731351
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20666.Liking for globe artichoke,35455,-0.027737873181057,0.0166399522225808,-0.0603521795373154,0.00487643317520133,0.09555251328838
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20667.Liking for goat's cheese,35455,-0.0181207053142815,0.0164591294605603,-0.0503805990569797,0.0141391884284166,0.270940584115137
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20668.Liking for going to a cafe,35455,0.00220304058791147,0.0166301357187216,-0.0303920254207829,0.0347981065966058,0.894612638924062
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20669.Liking for going to the gym,35455,-0.00449355127556592,0.0164956374680141,-0.0368250007128736,0.0278378981617418,0.785312819306016
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20670.Liking for going to the pub,35455,0.00806999369440219,0.0164431300989458,-0.0241585412995316,0.040298528688336,0.623589876378597
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20671.Liking for grapefruit,35455,-0.000528234402452027,0.01653745560299,-0.0329416473843124,0.0318851785794083,0.974519096084507
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20672.Liking for green olives,35455,-0.0279497458841982,0.0166609462253028,-0.0606052004857916,0.00470570871739532,0.0934598953126036
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20673.Liking for haddock,35455,0.00468614503951766,0.016841467306352,-0.0283231308809323,0.0376954209599676,0.780825112418405
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20674.Liking for ham,35455,0.0291078413089891,0.0166598036017465,-0.00354537375043399,0.0617610563684121,0.080630889733844
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20675.Liking for hard cheese,35455,0.0248503933532388,0.0169940593444069,-0.00845796296179869,0.0581587496682762,0.14368645812179
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20676.Liking for herring,35455,0.00292498896996343,0.0163947955267289,-0.0292088102624253,0.0350587882023521,0.858404427062841
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20677.Liking for honey,35455,-0.00241134871924216,0.0165204656933101,-0.03479146147813,0.0299687640396457,0.883954475215879
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20678.Liking for horseradish or wasabi,35455,-0.0328268833128789,0.016546050997862,-0.0652571432686883,-0.000396623357069373,0.0472826459734007
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20679.Liking for ice cream,35455,0.0408698387494685,0.0165849889875764,0.00836326033381877,0.0733764171651183,0.0137437943261183
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20680.Liking for jam,35455,0.0161847545149824,0.0165484273037731,-0.016250163000413,0.0486196720303778,0.328083010596413
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20681.Liking for kiwi fruit,35455,0.00702135868978291,0.0166129843230065,-0.0255400905833099,0.0395828079628757,0.672563716963544
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20682.Liking for lager,35455,-0.0226452580137191,0.0165444332146886,-0.0550723471145088,0.00978183108707061,0.171102742442888
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20683.Liking for lamb,35455,-0.00820218060345402,0.0167145047756477,-0.0409626099637234,0.0245582487568154,0.62363214976833
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20684.Liking for lemons,35455,-0.0167758514623509,0.0166464179374549,-0.0494028306197625,0.0158511276950607,0.313583316314678
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20685.Liking for lentils or beans,35455,-0.0263568965774811,0.0167433550695818,-0.0591738725138615,0.00646007935889927,0.115475328429847
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20686.Liking for liver,35455,0.0301967609713306,0.0166072895618322,-0.00235352656986062,0.0627470485125218,0.0690466193659392
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20687.Liking for mackerel,35455,-0.0076856975008814,0.0164789487471293,-0.0399844370452548,0.024613042043492,0.640941636706055
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20688.Liking for marzipan,35455,-0.0136608659232356,0.016381695956018,-0.0457689899970308,0.0184472581505597,0.404348692479135
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20689.Liking for mayonnaise,35455,0.00184164506203687,0.0165902940611343,-0.0306753312977864,0.0343586214218601,0.911612418045569
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20690.Liking for melon,35455,-0.0164831822136507,0.0170767911827851,-0.0499536929319094,0.016987328504608,0.334445340541855
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20691.Liking for milk chocolate,35455,0.0594251648251249,0.0167011490121708,0.0266909127612702,0.0921594168889796,0.000374971314282887
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20692.Liking for mushrooms,35455,-0.0269808173732606,0.0171057870515072,-0.0605081599942148,0.00654652524769358,0.114755703184874
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20694.Liking for orange juice,35455,0.0262015589828597,0.0165468531838387,-0.00623027325746418,0.0586333912231835,0.11334011245762
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20695.Liking for oranges,35455,-0.00292200721436485,0.0168858538451268,-0.0360182807508133,0.0301742663220836,0.862619328770232
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20696.Liking for pasta,35455,0.00101962083712625,0.0167223716918102,-0.0317562276788217,0.0337954693530743,0.951381398416294
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20697.Liking for pears,35455,0.000273684879844461,0.0167905083107968,-0.0326357114093173,0.0331830811690062,0.986995357478418
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20698.Liking for pizza,35455,0.00396774792956575,0.0165696226016193,-0.0285087123696081,0.0364442082287396,0.810753795819388
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20699.Liking for plain yogurt,35455,-0.002153759994413,0.0165890723617036,-0.0346683418233521,0.0303608218345261,0.896703146222311
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20700.Liking for plums,35455,-0.00511105435837737,0.0168453232645724,-0.0381278879569392,0.0279057792401845,0.761582202959527
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20701.Liking for pollock,35455,0.0123620043724816,0.0164838792529435,-0.0199463989632876,0.0446704077082509,0.453303001897756
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20702.Liking for pork chop,35455,0.0228929929189466,0.0164874775540778,-0.00942246308704582,0.055208448924939,0.165009132464167
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20703.Liking for porridge,35455,0.0189859423284773,0.0167857371465079,-0.0139141024786782,0.0518859871356329,0.258046569117198
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20704.Liking for potato crisps,35455,0.0233828833311106,0.0166371009130754,-0.00922583445851715,0.0559916011207384,0.159909501026639
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20705.Liking for potatoes,35455,0.0170113953958077,0.0168964644908527,-0.0161056750062635,0.0501284657978789,0.314050924588825
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20706.Liking for prawns,35455,0.0016462423337738,0.0166996144596997,-0.0310850020072376,0.0343774866747852,0.921473724818851
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20707.Liking for raw carrots,35455,-0.00695303343496629,0.0167559233417166,-0.0397946431847309,0.0258885763147983,0.678179066122468
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20708.Liking for red meat,35455,-0.00565596212348342,0.0166224991330379,-0.0382360604242376,0.0269241361772708,0.733667333136201
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20709.Liking for red wine,35455,-0.0209688845947653,0.0166269053210137,-0.0535576190239523,0.0116198498344216,0.20728317118581
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,35455,0.0323953169517508,0.0170956197417456,-0.00111209774207062,0.0659027316455723,0.0581241123449419
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20711.Liking for roast chicken,35455,0.0138920485698482,0.0173231873091262,-0.0200613985560391,0.0478454956957355,0.422607728912167
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20712.Liking for salad dressing,35455,-0.0168398736287086,0.01664953523235,-0.0494729626841146,0.0157932154266974,0.311830807361109
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20713.Liking for salad leaves,35455,-0.00530700890124438,0.0170291194725083,-0.0386840830673607,0.0280700652648719,0.755317323822583
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20714.Liking for salami,35455,-0.0271493027551572,0.0165671715213127,-0.0596209589369301,0.00532235342661573,0.101294369373773
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20715.Liking for salmon,35455,-0.0294677181309833,0.0171872472904518,-0.0631547228202689,0.00421928655830225,0.0864617304875006
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20716.Liking for salty foods,35455,0.00623109329922813,0.016511221540135,-0.0261309009194365,0.0385930875178928,0.705894156715746
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20717.Liking for salty pretzels,35455,-0.00230420821568896,0.0164537057574131,-0.0345534715002187,0.0299450550688407,0.888629319489737
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20718.Liking for sardines,35455,0.00184640077414764,0.0164533539019834,-0.0304021728737398,0.0340949744220351,0.910650655517685
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20719.Liking for sausages (meat),35455,0.0212805623673927,0.0165510222187047,-0.0111594411812686,0.053720565916054,0.19855421748149
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20720.Liking for savoury biscuits,35455,0.0136562804635949,0.0167324914742211,-0.0191394028258784,0.0464519637530683,0.414429162160211
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),35455,-0.0100893638683155,0.0165011353764998,-0.0424315892062551,0.0222528614696241,0.540923948516392
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20722.Liking for skimmed milk,35455,-0.00446494510710753,0.0165044585310603,-0.0368136838279857,0.0278837936137706,0.786757641582413
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20723.Liking for smoked fish,35455,0.000302698313801539,0.0165320428043828,-0.0321001055827888,0.0327055022103919,0.98539202882077
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20724.Liking for soft cheese,35455,0.0399643739604603,0.0165041759551092,0.00761618908844624,0.0723125588324744,0.015473113431296
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20725.Liking for soy sauce,35455,0.00935472282942333,0.0165680753751658,-0.0231187049059016,0.0418281505647483,0.572340885507488
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20726.Liking for soya milk,35455,-0.0281559628157128,0.0166465864062827,-0.0607832721720269,0.00447134654060122,0.0907881679348535
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20727.Liking for spicy foods,35455,-0.0184501206381485,0.0166606068007279,-0.0511049099675751,0.0142046686912781,0.268139744691612
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20728.Liking for spinach,35455,-0.0215717996872467,0.0166917979054138,-0.0542877235818577,0.0111441242073643,0.196258530573609
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20729.Liking for spirits,35455,0.00711524704720013,0.0165323398258865,-0.0252881390115374,0.0395186331059377,0.666924667295482
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20730.Liking for strawberries,35455,0.0300385670323245,0.0180033269795621,-0.00524795384761714,0.0653250879122661,0.0952433565732202
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,35455,0.00991174985436032,0.0169591522498361,-0.0233281885553185,0.0431516882640392,0.558930033266792
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20732.Liking for sweet foods,35455,0.0336463323555734,0.0165210110765442,0.00126515064554673,0.0660275140656001,0.041715010610279
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20733.Liking for taking the stairs,35455,0.0184299636542516,0.0169787313655706,-0.0148483498222668,0.0517082771307701,0.277734560825174
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20734.Liking for tea with sugar,35455,0.00756622735281706,0.0199620959762096,-0.0315594807605537,0.0466919354661878,0.704672750915415
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20735.Liking for tea without sugar,35455,0.00207029297488205,0.0173909187174046,-0.032015907711231,0.0361564936609951,0.905242175722026
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20736.Liking for tomato ketchup,35455,0.0276266465501608,0.0165520365274016,-0.00481534504354634,0.060068638143868,0.0951288621456382
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20737.Liking for tinned tuna,35455,-0.0063594404438101,0.016630682388722,-0.0389555779257053,0.0262366970380851,0.702177613190567
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20738.Liking for turnip (white),35455,-0.0205550477593859,0.0165065726975438,-0.0529079302465717,0.0117978347277999,0.213059752058642
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20739.Liking for vegetables,35455,0.0290206656071519,0.0182407716606322,-0.00673124684768727,0.0647725780619912,0.111641819395766
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20740.Liking for vinegar,35455,-0.0276613330311716,0.0164833511381888,-0.0599687012620215,0.00464603519967842,0.0933471895567245
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20741.Liking for watching television,35455,0.00542232149362371,0.016677827951931,-0.027266221292161,0.0381108642794085,0.745094940168785
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20742.Liking for whisky,35455,-0.0147342052206287,0.0172229724106149,-0.0484912311454339,0.0190228207041766,0.392293627110114
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20743.Liking for white bread,35455,0.011341327547905,0.016414647432567,-0.0208313814199263,0.0435140365157364,0.489625089609144
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20744.Liking for white rice,35455,0.00747773369872071,0.0166752553957944,-0.0252057668770364,0.0401612342744778,0.653849163729932
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20745.Liking for white wine,35455,0.0204438257960401,0.0164459375368358,-0.0117902117761581,0.0526778633682383,0.213858810263951
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,35455,0.0359161363854273,0.0166699818640171,0.00324297193195381,0.0685893008389007,0.0312184261697355
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20747.Liking for whole milk,35455,-0.00136766291189833,0.0164391629486925,-0.0335884222913356,0.030853096467539,0.933697599133817
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20748.Liking for wholemeal bread,35455,0.0268071785202447,0.0171704365627287,-0.00684687714270362,0.0604612341831929,0.118494362409255
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20749.Liking for working up a sweat,35455,0.019780337569594,0.0165762047383825,-0.0127090237176357,0.0522696988568238,0.232777459812322
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X21001.Body mass index (BMI),52167,0.0446409140375115,0.0248707353832408,-0.00410572731364055,0.0933875553886635,0.0726775361275397
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X21002.Weight,52188,-0.0547396273170744,0.0145158089652132,-0.0831906128888922,-0.0262886417452566,0.000162901975009304
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X21021.Pulse wave Arterial Stiffness index,33062,3.79852341255787e-05,0.0111970231175489,-0.0219081800762703,0.0219841505445215,0.997293302871794
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,34823,-0.0277801551635925,0.017615724300095,-0.0623069747917788,0.00674666446459378,0.114822328120032
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,34823,-0.00131975804973965,0.0184733922332831,-0.0375276068269745,0.0348880907274952,0.943048064433872
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,34823,0.000354526619368414,0.0181715389674304,-0.0352616897567951,0.035970742995532,0.984434619508109
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21040.Satisfaction with bowel habits,34793,-0.0318302083438134,0.0169292023387334,-0.0650114449277309,0.00135102824010418,0.060108038627355
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,34790,-0.0376324796938949,0.0178508725680088,-0.0726201899271922,-0.00264476946059767,0.0350399492409671
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21042.Greatest number of times bowels opened per day,34781,-0.00285010788297666,0.0183759724210856,-0.0388670138283044,0.0331667980623511,0.876745582121502
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21043.Least number of times bowels opened per week,34723,-0.00706538901513722,0.0180916271561617,-0.0425249782412141,0.0283942002109397,0.696149643344028
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21044.Average number of times bowels opened per day,34756,0.0116712893409112,0.0202292554236414,-0.0279780512894259,0.0513206299712482,0.563984478589085
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,34828,-0.000607622092466301,0.0183455753530355,-0.0365649497844159,0.0353497055994833,0.973578773372247
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,34823,-0.0190069619404648,0.0184516218954511,-0.0551721408555491,0.0171582169746194,0.302987160185754
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,30268,-0.0142971636109672,0.0271523736066641,-0.0675158158800288,0.0389214886580945,0.598522269660078
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,34825,-0.0241910220018312,0.0194675286783558,-0.0623473782114086,0.0139653342077461,0.214029140455885
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,34823,-0.0131173547719846,0.0277811518409546,-0.0675684123802557,0.0413337028362864,0.636816691907687
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,34826,0.0182578543583096,0.0219841910616867,-0.0248311601225962,0.0613468688392155,0.406274649337002
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,34824,0.070446911579916,0.0543375040723215,-0.0360545964018341,0.176948419561666,0.194841102790429
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,34826,0.00428577503973676,0.0207934810908071,-0.0364694478982451,0.0450409979777186,0.836707662739637
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,34826,-0.0206853782599533,0.0216825412445917,-0.063183159099353,0.0218124025794464,0.340099211954511
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,34576,-0.0156820828025753,0.0192604135999196,-0.0534324934584177,0.0220683278532672,0.415540926251688
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,34826,0.01304715277744,0.0191636870555834,-0.0245136738515035,0.0506079794063835,0.495995431946162
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,34827,0.0163704811388483,0.0263797092339563,-0.035333748959706,0.0680747112374027,0.534894856932736
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,34825,-0.015938900106443,0.0183602262837797,-0.0519249436226512,0.0200471434097651,0.385347033994605
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,34823,-0.0406273110172094,0.0183885509307314,-0.0766688708414428,-0.00458575119297591,0.0271687638442729
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X21100.Water hardness (USGS classification),51922,0.0431748598319649,0.0113940554378637,0.020842511173752,0.0655072084901778,0.000151421832669893
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X2139.Age first had sexual intercourse,49206,-0.00770251970335946,0.00668856630987277,-0.0208121096707101,0.00540707026399116,0.249498388268962
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2149.Lifetime number of sexual partners,47182,-0.0103975925198951,0.0128571066695836,-0.035597521592279,0.0148023365524888,0.418693724526566
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X22032.IPAQ activity group,47143,-0.0133887868293818,0.0123521122195583,-0.037598926779716,0.0108213531209524,0.278408431601967
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X22033.Summed days activity,47728,-0.00281381618057728,0.0064387691309415,-0.0154338036772226,0.00980617131606807,0.662106958787405
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X22034.Summed minutes activity,47143,-0.0036200761894332,0.0065861072414095,-0.0165288463825958,0.00928869400372942,0.58256240194749
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X22037.MET minutes per week for walking,46372,-0.00284317488424807,0.00646334698726311,-0.0155113349792838,0.00982498521078764,0.660019525084943
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X22038.MET minutes per week for moderate activity,47143,0.00362582530043641,0.00674492179029139,-0.00959422140853471,0.0168458720094075,0.590883415175036
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X22039.MET minutes per week for vigorous activity,47143,-0.0198288970563604,0.012341305885855,-0.0440178565926361,0.00436006247991535,0.108131604841025
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X22040.Summed MET minutes per week for all activity,46372,-0.00741257178425107,0.00665765521300453,-0.02046157600174,0.00563643243323781,0.26555253033667
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X2217.Age started wearing glasses or contact lenses,46530,-0.00210075647997305,0.00769296821943546,-0.0171789741900666,0.0129774612301205,0.784798132755783
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X22501.Year ended full time education,31430,0.0227789209239438,0.0327769439542225,-0.0414638892263323,0.0870217310742199,0.487096805815979
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X22506.Tobacco smoking,31380,0.0787987768665719,0.0436002120585919,-0.00665763876826833,0.164255192501412,0.0707550669858932
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,50223,-0.0115138531347501,0.0249343977845841,-0.0603852727925349,0.0373575665230347,0.644253060548661
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23098.Weight,51811,-0.0533800776995143,0.0146057381984009,-0.0820073245683799,-0.0247528308306486,0.000257920678110025
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23099.Body fat percentage,51789,0.0494653040003112,0.0141551919250483,0.0217211278272166,0.0772094801734059,0.000475688052786456
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23100.Whole body fat mass,51752,0.00218577735160023,0.0134690639952718,-0.0242135880791326,0.028585142782333,0.871085507470907
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23101.Whole body fat-free mass,51806,-0.0717519529454859,0.012471685610786,-0.0961964567426265,-0.0473074491483454,8.84895184908455e-09
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23102.Whole body water mass,51811,-0.0702090520594062,0.0124711540493664,-0.0946525139961643,-0.0457655901226482,1.8223662727472e-08
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23104.Body mass index (BMI),51811,0.0495342484832782,0.025050159834688,0.00043593520728976,0.0986325617592666,0.0480059610626615
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23105.Basal metabolic rate,51809,-0.0747623402677366,0.0133685418119753,-0.100964682219208,-0.048559998316265,2.26033005237622e-08
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23106.Impedance of whole body,51808,0.0401522888820571,0.0102672074509181,0.0200285622782576,0.0602760154858567,9.22344677651998e-05
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23107.Impedance of leg (right),51808,0.0631576407130955,0.00845755808507279,0.0465808268663528,0.0797344545598382,8.40558832727936e-14
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23108.Impedance of leg (left),51807,0.0593163016995469,0.00839530285578865,0.0428615081022011,0.0757710952968926,1.63886747783844e-12
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23109.Impedance of arm (right),51801,0.00969346574831807,0.0102962641703522,-0.0104872120255722,0.0298741435222084,0.346480059827822
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23110.Impedance of arm (left),51806,0.00353678397473328,0.0102879734552467,-0.0166276439975503,0.0237012119470168,0.731015464589569
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23111.Leg fat percentage (right),51807,0.115711399213302,0.017504862153096,0.0814018693932338,0.15002092903337,3.90593273581792e-11
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23112.Leg fat mass (right),51806,0.0482934615294404,0.0181681824349609,0.0126838239569171,0.0839030991019638,0.00786193930186296
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23113.Leg fat-free mass (right),51806,-0.101963485546281,0.013415648637464,-0.12825815687571,-0.0756688142168518,3.04603493439238e-14
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23114.Leg predicted mass (right),51805,-0.102540239054127,0.0134653193762492,-0.128932265031576,-0.0761482130766788,2.71727095654724e-14
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23115.Leg fat percentage (left),51804,0.116284213296376,0.0181077715529898,0.0807929810525164,0.151775445540236,1.36848405225068e-10
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23116.Leg fat mass (left),51804,0.0410959203052822,0.0188795798842096,0.00409194373223139,0.0780998968783331,0.0295083795353545
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23117.Leg fat-free mass (left),51802,-0.0998347332687822,0.0139088220509467,-0.127096024488638,-0.0725734420489267,7.26092029792083e-13
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23118.Leg predicted mass (left),51801,-0.0994020262195368,0.0139612599126627,-0.126766095648356,-0.0720379567907179,1.10656747400386e-12
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23119.Arm fat percentage (right),51801,0.0301607880217931,0.0155849271916255,-0.00038566927379282,0.060707245317379,0.052969248874191
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23120.Arm fat mass (right),51798,-0.00522470056478813,0.0152453547667847,-0.0351055959076862,0.0246561947781099,0.73182094289538
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23121.Arm fat-free mass (right),51798,-0.0487208330437505,0.0124786040402435,-0.0731788969626277,-0.0242627691248732,9.47009845095407e-05
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23122.Arm predicted mass (right),51797,-0.0490776650919373,0.0124868145852907,-0.073551821679107,-0.0246035085047676,8.50233498882252e-05
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23123.Arm fat percentage (left),51793,0.0197713279281734,0.015941244446054,-0.0114735111860925,0.0510161670424393,0.214888730232674
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23124.Arm fat mass (left),51792,-0.00397639921856729,0.0151776383571702,-0.0337245703986208,0.0257717719614862,0.793330588728346
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23125.Arm fat-free mass (left),51788,-0.0413577375602873,0.0126809014314039,-0.0662123043658389,-0.0165031707547357,0.00110988838499545
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23126.Arm predicted mass (left),51787,-0.0324495766102013,0.0127515267792328,-0.0574425690974976,-0.00745658412290505,0.0109406169617036
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23127.Trunk fat percentage,51784,0.0180217534915696,0.0101499277825101,-0.00187210496215012,0.0379156119452893,0.0758172063393059
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23128.Trunk fat mass,51780,-0.00512168672663488,0.0110728610986553,-0.0268244944799992,0.0165811210267295,0.643694779550027
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23129.Trunk fat-free mass,51774,-0.0547049148141003,0.0113611983132362,-0.0769728635080433,-0.0324369661201574,1.47921712740745e-06
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23130.Trunk predicted mass,51772,-0.0546088894397482,0.0113447950323076,-0.0768446877030711,-0.0323730911764252,1.49037667243638e-06
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23400.Total Cholesterol,39931,0.0868304021355145,0.00854700795549533,0.0700782665427437,0.103582537728285,3.56922909663926e-24
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,39931,0.0918703511747328,0.00829335766251361,0.0756153701562061,0.108125332193259,2.04238138260612e-28
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",39931,0.0909490346966396,0.00832862214885478,0.0746249352848842,0.107273134108395,1.15622111826271e-27
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23403.VLDL Cholesterol,39931,0.0966208167729331,0.00820439704521955,0.0805401985643027,0.112701434981563,6.9590956992278e-32
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23404.Clinical LDL Cholesterol,39931,0.0791955410240353,0.00829427360034157,0.0629387647673658,0.0954523172807048,1.50506825595595e-21
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23405.LDL Cholesterol,39931,0.0885772379562202,0.00822135239585557,0.0724633872603433,0.104691088652097,5.64389352772277e-27
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23406.HDL Cholesterol,39931,0.00447317072907465,0.0094110623156097,-0.0139725114095204,0.0229188528676697,0.634572590660615
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23407.Total Triglycerides,39931,0.111057106244389,0.00840825594002155,0.0945769246019464,0.127537287886831,1.2674121372175e-39
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23408.Triglycerides in VLDL,39931,0.10723130965697,0.00854858487336854,0.0904760833051679,0.123986536008773,6.33730306926239e-36
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23409.Triglycerides in LDL,39931,0.115872798771419,0.00801513892750428,0.10016312647351,0.131582471069327,4.48712711106583e-47
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23410.Triglycerides in HDL,39931,0.101173025825379,0.00794095228070537,0.0856087593551969,0.116737292295562,5.30609283860632e-37
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,39931,0.102125083437198,0.0084533010359205,0.0855566134067936,0.118693553467602,1.85645556968807e-33
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23412.Phospholipids in VLDL,39931,0.105415296935975,0.00828864253273549,0.0891695575718131,0.121661036300136,7.06905620566615e-37
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23413.Phospholipids in LDL,39931,0.0890349294102488,0.00822719211435305,0.0729096328661168,0.105160225954381,3.35964024272281e-27
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23414.Phospholipids in HDL,39931,0.0400316354102587,0.00883616503220746,0.0227127519471321,0.0573505188733854,5.92873417187284e-06
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23415.Total Esterified Cholesterol,39931,0.0849584252343554,0.00858003913225011,0.0681415485351452,0.101775301933566,4.75619650698519e-23
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,39931,0.0903023664241611,0.00820729721047717,0.0742160638916258,0.106388668956696,4.67071600247798e-28
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,39931,0.0948369370604462,0.00818647326974157,0.0787914494517527,0.11088242466914,6.54532914719553e-31
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,39931,-0.00219574908512269,0.00939342046067592,-0.0206068531880475,0.0162153550178021,0.815178983358096
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23419.Total Free Cholesterol,39931,0.0895539853936505,0.00845958575758021,0.0729731973087933,0.106134773478508,4.21375177023501e-26
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23420.Free Cholesterol in VLDL,39931,0.103078095905908,0.00824835330143894,0.0869113234350876,0.119244868376728,1.13833777862544e-35
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23421.Free Cholesterol in LDL,39931,0.0684323108941593,0.00833147113876316,0.0521026274621835,0.0847619943261351,2.30620526790151e-16
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23422.Free Cholesterol in HDL,39931,0.0259779734905619,0.00933138341094462,0.00768846200511043,0.0442674849760133,0.0053766402551855
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,39931,0.109698449668717,0.00823213844659135,0.0935634583133984,0.125833441024036,2.68730160114207e-40
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23424.Total Lipids in VLDL,39931,0.108953864421925,0.00836595944927136,0.0925565839013533,0.125351144942497,1.41064654412702e-38
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23425.Total Lipids in LDL,39931,0.0935009817591945,0.00820799727935694,0.0774133070916549,0.109588656426734,6.00944622031806e-30
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23426.Total Lipids in HDL,39931,0.0333266218098628,0.00903158735475072,0.0156247105945514,0.0510285330251742,0.000224988157425977
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,39931,0.0808126205091276,0.00849813226832713,0.0641562812632064,0.0974689597550487,2.18165438166316e-21
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23428.Concentration of VLDL Particles,39931,0.102230840599584,0.00818312025595378,0.086191924897915,0.118269756301254,1.19523492073531e-35
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23429.Concentration of LDL Particles,39931,0.0825005070167223,0.00823224574375731,0.066365305358958,0.0986357086744866,1.43625999617139e-23
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23430.Concentration of HDL Particles,39931,0.0704383823168221,0.00850391552435063,0.0537707078890949,0.0871060567445493,1.29424824863379e-16
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,39931,0.0960057240119176,0.00899890506646909,0.0783678700816382,0.113643577942197,1.75082604135487e-26
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23432.Average Diameter for LDL Particles,39931,-0.0383989058626201,0.00824154301367121,-0.0545523301694156,-0.0222454815558245,3.20003638293314e-06
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23433.Average Diameter for HDL Particles,39931,-0.0723964329141989,0.00954633777451147,-0.0911072549522413,-0.0536856108761564,3.54190391110458e-14
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23434.Phosphoglycerides,39920,0.0982541268325371,0.00836254199157049,0.0818635445290589,0.114644709136015,9.60287419274571e-32
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,39920,0.0839465952976406,0.00902849123966365,0.0662507524678999,0.101642438127381,1.61185738502908e-20
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23436.Total Cholines,39920,0.0974635868450252,0.00850448756133349,0.0807947912248115,0.114132382465239,2.73959996740916e-30
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23437.Phosphatidylcholines,39920,0.0842171783492187,0.00849382458852743,0.0675692821557049,0.100865074542732,4.16985771001781e-23
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23438.Sphingomyelins,39919,0.094001536010485,0.00877453530156153,0.0768034468194244,0.111199625201546,1.08866146345366e-26
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23439.Apolipoprotein B,39931,0.0848588612055366,0.0082583980838319,0.068672400961226,0.101045321449847,1.08393101063763e-24
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23440.Apolipoprotein A1,39931,0.0512663990071913,0.00877279940492665,0.0340717121735351,0.0684610858408475,5.20136263597061e-09
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,39931,0.0459449319101111,0.00827751590409987,0.0297210007380753,0.0621688630821468,2.89242928450681e-08
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23442.Total Fatty Acids,39920,0.119903038693968,0.00801161339182603,0.104200276445989,0.135605800941947,2.6673119016816e-50
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23443.Degree of Unsaturation,39920,-0.0813608811761577,0.00892202140608495,-0.0988480431320842,-0.0638737192202312,8.45392239815805e-20
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23444.Omega-3 Fatty Acids,39920,0.0191858857702872,0.00819953942032556,0.00311478850644914,0.0352569830341253,0.0193024498787998
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23445.Omega-6 Fatty Acids,39920,0.102162906247968,0.00814025694309614,0.0862080026394994,0.118117809856436,5.83836327099019e-36
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,39920,0.0915591362278798,0.00815716767185011,0.0755710875910536,0.107547184864706,3.97354701158195e-29
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,39920,0.128257983629142,0.00814421966236094,0.112295313090915,0.14422065416737,1.83283405097089e-55
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23448.Saturated Fatty Acids,39920,0.124790722322804,0.00805004872348731,0.109012626824769,0.140568817820839,8.26794172009359e-54
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23449.Linoleic Acid,39920,0.100969670933102,0.00819756647319717,0.0849024406456357,0.117036901220569,1.05205241728512e-34
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23450.Docosahexaenoic Acid,39920,-0.00669799394211848,0.00856666204215725,-0.0234886515447467,0.0100926636605097,0.434304020711485
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,39920,-0.0484415489577853,0.00828174586474608,-0.0646737708526876,-0.032209327062883,5.03556064073428e-09
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,39920,-0.0946759071290777,0.00841758825527231,-0.111174380109411,-0.0781774341487439,3.06824722925656e-29
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,39920,-0.123508407229634,0.00873399507084408,-0.140627037568489,-0.10638977689078,3.9531691276711e-45
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,39920,0.111341240393356,0.00893138931585503,0.0938357173342797,0.128846763452431,1.66454725610081e-35
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,39920,0.0743066487586423,0.00806685899989225,0.0584956051188535,0.0901176923984311,3.61049276465822e-20
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,39920,-0.0351793587072579,0.0086396526712191,-0.0521130779428473,-0.0182456394716685,4.68650316034714e-05
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,39920,-0.0869935402632949,0.00863846097042069,-0.103924923765319,-0.0700621567612703,8.77745479136051e-24
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,39920,-0.12344616946008,0.00891634194113343,-0.140922199664702,-0.105970139255459,2.42189395991324e-43
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,39918,0.0208160703942581,0.00822119165008718,0.00470253476008725,0.036929606028429,0.0113507981537693
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23460.Alanine,39927,0.0831169459756428,0.00795594332038591,0.0675232970676864,0.0987105948835992,1.82201709233989e-25
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23461.Glutamine,39887,-0.129849142844805,0.00782494207820996,-0.145186029318097,-0.114512256371514,2.49033761763846e-61
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23462.Glycine,39912,0.0442172729131494,0.00830030113102985,0.0279486826963309,0.0604858631299679,1.01089863665803e-07
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23463.Histidine,39914,0.0209675122656037,0.00788676836385853,0.005509446272441,0.0364255782587665,0.00785512512151622
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),39920,0.0579781731542016,0.00840910247553864,0.0414963323021459,0.0744600140062573,5.5992308574942e-12
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23465.Isoleucine,39929,0.0328987960182149,0.00820790781848635,0.0168112966939817,0.0489862953424482,6.14638194558106e-05
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23466.Leucine,39930,0.0519108898998652,0.00846574337436928,0.0353180328861014,0.068503746913629,8.88796048562845e-10
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23467.Valine,39920,0.0639840829112318,0.00837374113399332,0.0475715502886049,0.0803966155338587,2.27598972190414e-14
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23468.Phenylalanine,39928,0.0262337550302931,0.00796743754147899,0.0106175774489942,0.0418499326115919,0.000994723245084498
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23469.Tyrosine,39915,0.0492713849376951,0.00812981910493376,0.0333369394920249,0.0652058303833653,1.3866682851983e-09
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23470.Glucose,39905,-0.0591342326230795,0.00812551084041268,-0.0750602338702883,-0.0432082313758706,3.55534322423987e-13
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23471.Lactate,39903,0.239247348172095,0.00776003301810301,0.224037683456613,0.254457012887577,7.99467065680919e-203
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23472.Pyruvate,39883,0.121519082240349,0.00783786013553519,0.1061568763747,0.136881288105998,8.00324185234594e-54
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23473.Citrate,39929,0.0416665405946921,0.00807123767847936,0.0258469147448726,0.0574861664445116,2.46778923487144e-07
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23474.3-Hydroxybutyrate,39675,0.0570510635147575,0.00784968946707369,0.041665672159293,0.0724364548702219,3.82067964453821e-13
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23475.Acetate,39917,-0.13222954874438,0.00792383544059393,-0.147760266207944,-0.116698831280815,5.37080418180294e-62
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23476.Acetoacetate,39931,-0.0155286205544567,0.00783707517701632,-0.0308892879014087,-0.000167953207504736,0.0475600187021073
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23477.Acetone,39931,-0.0515825975308816,0.00786891981869976,-0.0670056803755332,-0.0361595146862301,5.72469561259195e-11
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23478.Creatinine,39505,0.0324594885260508,0.00986333977974737,0.0131273425577459,0.0517916344943556,0.00100080340995016
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23479.Albumin,39930,0.052775246465653,0.00809733969584816,0.0369044606617907,0.0686460322695154,7.35660395576648e-11
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23480.Glycoprotein Acetyls,39931,0.218300907266275,0.00831616723646751,0.202001219482799,0.234600595049751,9.55369079224034e-149
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,39931,0.0927814302279278,0.00850571001809924,0.0761102385924533,0.109452621863402,1.31705212792014e-27
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,39931,0.0887974314201952,0.00854669924148098,0.0720459009068925,0.105548961933498,3.3203593839275e-25
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,39931,0.095474647667045,0.00855192649539184,0.078712871736077,0.112236423598013,7.80050141767599e-29
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,39931,0.101645861637185,0.0084799928691012,0.0850250756137471,0.118266647660624,5.77681750600625e-33
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,39931,0.104556459274431,0.00851442201760474,0.087868192119926,0.121244726428937,1.65786847801852e-34
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,39931,0.0956743516421482,0.00841267359361265,0.0791855113986674,0.112163191885629,7.44290076128735e-30
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,39931,0.0783539218835548,0.00854135652051701,0.0616128631033415,0.0950949806637682,5.12483373234806e-20
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,39931,0.108662077351856,0.00866138222433183,0.0916857681921653,0.125638386511546,6.19383202251762e-36
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,39931,0.10690144288703,0.00866872588640293,0.08991074014968,0.12389214562438,8.76656217511219e-35
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,39931,0.103544402783035,0.00861451456456669,0.0866599542364846,0.120428851329586,3.88088083543584e-33
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,39931,0.103603780943038,0.00848519087929908,0.0869728068196115,0.120234755066464,3.89618630182548e-34
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,39931,0.101732868902493,0.0084080345983824,0.0852531210896631,0.118212616715322,1.4870631660862e-33
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,39931,0.101177007762719,0.00854685625296857,0.0844251695069002,0.117928846018537,3.3820399421643e-32
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,39931,0.10532509317926,0.0087472523810088,0.0881804785124823,0.122469707846037,3.00983495138986e-33
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,39931,0.107602378403916,0.00856712046742674,0.0908108222877592,0.124393934520072,5.17662376407705e-36
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23496.Total Lipids in Large VLDL,39931,0.106268847108844,0.00857841213306088,0.0894551593280448,0.123082534889644,4.39207411998606e-35
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23497.Phospholipids in Large VLDL,39931,0.107050527145049,0.00862148306542952,0.0901524203368074,0.123948633953291,3.07709592441712e-35
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23498.Cholesterol in Large VLDL,39931,0.104565179233889,0.00842663226991811,0.0880489799848492,0.121081378482928,3.38994470735986e-35
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,39931,0.0970873463038374,0.00829254920495319,0.0808339498621292,0.113340742745546,1.56161603817449e-31
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,39931,0.109669312303957,0.00858001806277747,0.0928524769009135,0.126486147707001,3.13999292302274e-37
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23501.Triglycerides in Large VLDL,39931,0.10295525270252,0.00863084759754926,0.0860387914113235,0.119871713993717,1.1514413401742e-32
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,39931,0.0959193915718883,0.00819666464705708,0.0798539288636564,0.11198485428012,1.66597401149176e-31
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,39931,0.102413035376852,0.00822517804074936,0.0862916864169835,0.118534384336721,2.00786334894074e-35
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,39931,0.0942113844787397,0.00819521668116534,0.0781487597836557,0.110274009173824,1.81989811313116e-30
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,39931,0.0684566640416763,0.00828703484870097,0.0522140757382223,0.0846992523451302,1.56003588419215e-16
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,39931,0.0506598483380996,0.00839036954633066,0.0342147240272915,0.0671049726489077,1.5961084204299e-09
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,39931,0.0864158566644672,0.00819564481379406,0.0703523928294308,0.102479320499504,6.57094944017698e-26
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,39931,0.109910833530357,0.0084318492822099,0.0933844089372253,0.126437258123488,1.21168213168894e-38
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,39931,0.102538113011691,0.00822226428008017,0.0864224750227337,0.118653751000648,1.57354560231893e-35
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23510.Total Lipids in Small VLDL,39931,0.106808322164385,0.00819876725808253,0.0907387383385436,0.122877905990227,1.34129511649755e-38
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23511.Phospholipids in Small VLDL,39931,0.0990381740045705,0.00815048907269409,0.0830632154220901,0.115013132587051,7.9556709342336e-34
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23512.Cholesterol in Small VLDL,39931,0.0913041829368976,0.00817093701340272,0.0752891463906283,0.107319219483167,6.96428086308924e-29
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,39931,0.0926472080619782,0.00818404807455019,0.0766064738358598,0.108687942288097,1.34522160544914e-29
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,39931,0.0873060077225782,0.00817637096689825,0.0712803206274576,0.103331694817699,1.5861150682294e-26
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23515.Triglycerides in Small VLDL,39931,0.103563014350536,0.00830383474370427,0.0872874982528761,0.119838530448197,1.55562118315976e-35
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,39931,0.08496537346365,0.00821894694368512,0.0688562374540272,0.101074509473273,5.69498480184582e-25
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,39931,0.0825628844160115,0.00819675669399968,0.0664972412957722,0.0986285275362509,8.5889193123737e-24
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,39931,0.0768498004563166,0.00815135516133222,0.0608731443401054,0.0928264565725278,4.74378826201752e-21
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,39931,0.0671808441898401,0.00851002757196536,0.050501190148788,0.0838604982308922,3.1064038143127e-15
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,39931,0.0626571985607431,0.00862474317168157,0.0457527019442472,0.079561695177239,3.90677159555368e-13
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,39931,0.0749497066091931,0.00826145641781846,0.058757252030269,0.0911421611881173,1.2986527008774e-19
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,39931,0.0957955057674303,0.00807023286329143,0.079977849355379,0.111613162179481,2.30749006995297e-32
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23523.Concentration of IDL Particles,39931,0.0680402648911607,0.00845056986301861,0.0514771479596442,0.0846033818226772,8.74278056836931e-16
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23524.Total Lipids in IDL,39931,0.0772410513020386,0.00864069475659427,0.0603052895791139,0.0941768130249634,4.33793014880203e-19
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23525.Phospholipids in IDL,39931,0.0725207298993047,0.00864009303228426,0.0555861475560275,0.0894553122425819,5.10696030639123e-17
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23526.Cholesterol in IDL,39931,0.0684986443335354,0.00869828237331734,0.0514500108818334,0.0855472777852374,3.62496769096516e-15
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,39931,0.0693533819718044,0.00868466717193866,0.0523314343148047,0.0863753296288042,1.49087727849131e-15
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23528.Free Cholesterol in IDL,39931,0.0639390791044796,0.00870135225598484,0.0468844286827493,0.0809937295262099,2.10579281812293e-13
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23529.Triglycerides in IDL,39931,0.098587058537911,0.00795687125176378,0.082991590884454,0.114182526191368,4.27223858185144e-35
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23530.Concentration of Large LDL Particles,39931,0.0718658861866939,0.00825017822763949,0.0556955368605205,0.0880362355128673,3.30607692577549e-18
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23531.Total Lipids in Large LDL,39931,0.088698240675297,0.00827499408785519,0.0724792522631008,0.104917229087493,1.02242494004545e-26
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23532.Phospholipids in Large LDL,39931,0.0872006820220393,0.00830344668210884,0.070925926525106,0.103475437518973,1.02721421130738e-25
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23533.Cholesterol in Large LDL,39931,0.082504999818835,0.00829326056387691,0.0662502091136363,0.0987597905240337,2.99060417473356e-23
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,39931,0.0871899762285029,0.00824355686553644,0.0710326047720515,0.103347347684954,4.65296801893145e-26
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,39931,0.067341758463439,0.00844043558303222,0.0507985047206959,0.0838850122061822,1.58082264089346e-15
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23536.Triglycerides in Large LDL,39931,0.11297710911393,0.00796940519042691,0.0973570749406929,0.128597143287166,2.40808860590096e-45
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,39931,0.0968216559360144,0.00818651824731202,0.0807760801712828,0.112867231700746,3.84937861681504e-32
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23538.Total Lipids in Medium LDL,39931,0.103006797684777,0.00814343406517414,0.0870456669170352,0.118967928452518,1.68994812203459e-36
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23539.Phospholipids in Medium LDL,39931,0.098046481515519,0.00813237488832186,0.0821070267344082,0.11398593629663,2.50169982707558e-33
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23540.Cholesterol in Medium LDL,39931,0.0995871213769564,0.00814943137500822,0.0836142358819403,0.115560006871973,3.4418101078908e-34
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,39931,0.106335315875885,0.00815655868876099,0.0903484608459139,0.122322170905857,1.18697732682666e-38
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,39931,0.0752101387598398,0.00816534325798933,0.0592060659741807,0.0912142115454989,3.62533461945735e-20
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23543.Triglycerides in Medium LDL,39931,0.118956228883554,0.00807866027175927,0.103122054750906,0.134790403016202,9.29208508642e-49
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23544.Concentration of Small LDL Particles,39931,0.0871033463112505,0.00822720419932575,0.070978026080572,0.103228666541929,4.16313791125395e-26
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23545.Total Lipids in Small LDL,39931,0.0881568834470721,0.00820811885365455,0.0720689704939091,0.104244796400235,8.12610066490307e-27
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23546.Phospholipids in Small LDL,39931,0.0648520121525093,0.00823115389281146,0.0487189505225989,0.0809850737824198,3.5144256805178e-15
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23547.Cholesterol in Small LDL,39931,0.0886347708386059,0.00819855626599823,0.0725656005572493,0.104703941119962,3.78501409140738e-27
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,39931,0.0996827885246904,0.00819500492713937,0.0836205788674973,0.115744998181884,6.82393757968344e-34
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,39931,0.0516883169810683,0.00819561394717569,0.035624913644604,0.0677517203175327,2.92256516874342e-10
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23550.Triglycerides in Small LDL,39931,0.113876384440261,0.00819312227636921,0.0978178647785772,0.129934904101944,1.14904026111888e-43
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,39931,-0.0499397818510931,0.00962502091888194,-0.0688048228521017,-0.0310747408500845,2.14529359652692e-07
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,39931,-0.0719780303612477,0.00964780632093274,-0.0908877307502759,-0.0530683299722195,9.0554950019119e-14
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,39931,-0.0767615441879046,0.00953829826491607,-0.09545660878714,-0.0580664795886691,9.02031380311154e-16
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,39931,-0.0770692853104053,0.00978745547770479,-0.0962526980467067,-0.0578858725741039,3.64436446351588e-15
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,39931,-0.0777972893391695,0.0099050228590864,-0.0972111341429789,-0.0583834445353602,4.27184374431063e-15
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,39931,-0.0704753065863439,0.00921298963548884,-0.0885327662719021,-0.0524178469007858,2.13059629120018e-14
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,39931,0.0719783906270437,0.00782306619556721,0.056645180883732,0.0873116003703554,3.98115269338048e-20
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23558.Concentration of Large HDL Particles,39931,-0.0491837905166383,0.00985680746170143,-0.0685031331415731,-0.0298644478917035,6.1064082377416e-07
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23559.Total Lipids in Large HDL,39931,-0.0456065475080982,0.00971189762722937,-0.0646418668574678,-0.0265712281587287,2.6756914436677e-06
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23560.Phospholipids in Large HDL,39931,-0.034579315509808,0.00951180184029862,-0.0532224471167933,-0.0159361839028227,0.000278403542401941
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23561.Cholesterol in Large HDL,39931,-0.0675178017839397,0.00993320170646987,-0.0869868771286206,-0.0480487264392588,1.1043557560482e-11
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,39931,-0.0724703923887483,0.00994966274861222,-0.0919717313760282,-0.0529690534014683,3.39836673764329e-13
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,39931,-0.0492819848544133,0.00981002768660333,-0.0685096391201558,-0.0300543305886708,5.12468197749765e-07
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23564.Triglycerides in Large HDL,39931,0.0621804996608735,0.00790258109679197,0.0466914407111612,0.0776695586105857,3.82010606389719e-15
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,39931,0.0475145381270473,0.00867435350612956,0.0305128052550334,0.0645162709990612,4.3763711402609e-08
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23566.Total Lipids in Medium HDL,39931,0.0546134665118995,0.00852992330049558,0.0378948168429282,0.0713321161808709,1.57016140608993e-10
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23567.Phospholipids in Medium HDL,39931,0.0614654011649971,0.00838426623119537,0.0450322393518542,0.0778985629781401,2.39238671053851e-13
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23568.Cholesterol in Medium HDL,39931,0.031409215141386,0.00881176462336797,0.0141381564795848,0.0486802738031872,0.000365658175421467
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,39931,0.027249025785363,0.00879582133784715,0.0100092159631826,0.0444888356075434,0.00195199434532489
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,39931,0.0466474206710774,0.00883000459060461,0.0293406116734923,0.0639542296686624,1.28861795821216e-07
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23571.Triglycerides in Medium HDL,39931,0.102368822707347,0.00796550268350388,0.0867564374476792,0.117981207967014,1.2919988933814e-37
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23572.Concentration of Small HDL Particles,39931,0.10584475610034,0.00789340588656977,0.0903736805626633,0.121315831638017,8.84070040244826e-41
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23573.Total Lipids in Small HDL,39931,0.116596768417636,0.00791551243528872,0.10108236404447,0.132111172790801,8.58605250838725e-49
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23574.Phospholipids in Small HDL,39931,0.113193456998624,0.00792859572070331,0.0976534093860456,0.128733504611203,5.84739942274606e-46
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23575.Cholesterol in Small HDL,39931,0.0970836992679303,0.0078926154072032,0.081614173069812,0.112553225466049,1.28719565089711e-34
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,39931,0.0867415104104578,0.00787354416030336,0.0713093638562632,0.102173656964652,3.99703770219551e-28
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,39931,0.113894461565662,0.00800025313261335,0.0982139654257403,0.129574957705585,1.03339305729558e-45
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23578.Triglycerides in Small HDL,39931,0.123853559856664,0.00855927067709452,0.107077389329559,0.14062973038377,3.70431923065481e-47
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39162,0.0497474837326798,0.00806319245034525,0.0339436265300032,0.0655513409353565,7.01417866520838e-10
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39162,0.011432127073775,0.00806386954914892,-0.0043730572425569,0.0272373113901069,0.156299484924135
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39162,0.0196459553811654,0.00798990653729944,0.00398573856805846,0.0353061721942723,0.0139494021212582
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39162,-0.00765427948804932,0.00819371349335587,-0.0237139579350268,0.00840539895892818,0.350233582587916
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39162,-0.0237655605009206,0.00790716532458676,-0.0392636045371106,-0.00826751646473052,0.00265510830493345
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,39743,0.0205071182175543,0.00783792929373855,0.00514477680182674,0.0358694596332819,0.00889478321947374
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,39743,-0.0562557870801456,0.00872187238349754,-0.0733506569518008,-0.0391609172084905,1.15107726768071e-10
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,39743,-0.0535934051478943,0.0086904590631904,-0.0706267049117475,-0.0365601053840411,7.13160733625819e-10
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,39743,-0.0516276616730586,0.00835869131197934,-0.0680106966445381,-0.0352446267015791,6.71236181014335e-10
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,39743,0.0397648820895591,0.00847611621810921,0.023151694302065,0.0563780698770531,2.73598176529623e-06
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,39927,0.072899788730577,0.00849110659357067,0.0562572198071784,0.0895423576539755,9.86805537031414e-18
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,39927,-0.00803770975733663,0.00819256962504848,-0.0240951462224317,0.00801972670775838,0.326559424937888
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,39927,-0.0292341046080168,0.00853930347550825,-0.045971139420013,-0.0124970697960207,0.000619798555379173
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,39927,0.0416613969771451,0.00798699595264261,0.0260068849099656,0.0573159090443246,1.84944962059434e-07
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,39927,-0.024501163525985,0.00787296032943927,-0.039932165771686,-0.00907016128028403,0.0018610942530096
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,39931,-0.0080405960609155,0.00860740321578141,-0.0249111063638471,0.00882991424201606,0.350241136576679
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,39931,-0.0491730766775092,0.00895906263133407,-0.066732839434924,-0.0316133139200944,4.11169559379863e-08
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,39931,-0.055653570708808,0.00898564409198826,-0.073265433129105,-0.038041708288511,6.02321769096411e-10
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,39931,-0.0285552980008486,0.0087979071677303,-0.0457991960496,-0.0113113999520972,0.0011740528358095
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,39931,0.0402541116175945,0.00890798799111892,0.0227944551550014,0.0577137680801876,6.26114558842625e-06
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,39931,-0.0288947105844812,0.0085557412003565,-0.0456639633371799,-0.0121254578317824,0.000733932789612257
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,39931,-0.0211537106323506,0.00827692779164898,-0.0373764891039826,-0.00493093216071864,0.0106052158663115
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,39931,-0.0117557643150761,0.00805064135175799,-0.0275350213645218,0.00402349273436954,0.144247229606017
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,39931,-0.0331456845820809,0.00861813333451066,-0.0500372259177218,-0.0162541432464401,0.000120505482310856
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,39931,0.0237219009979197,0.00836385560511257,0.00732874401189911,0.0401150579839404,0.00457051984595345
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,39931,-0.0286965133073142,0.00835970180941034,-0.0450815288537584,-0.0123114977608699,0.000599065034209299
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,39931,-0.0372430943799302,0.00879489062288109,-0.0544810800007772,-0.0200051087590833,2.30202891236335e-05
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,39931,-0.0372218695532834,0.00889396549678162,-0.0546540419269753,-0.0197896971795914,2.8659373307403e-05
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,39931,-0.0265223863447579,0.0080150618682425,-0.0422319076065132,-0.0108128650830026,0.000938128334253164
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,39931,0.0495067752668388,0.00870600132185675,0.0324430126759996,0.066570537857678,1.31915088328386e-08
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,39931,-0.0452316960687136,0.00804274081549794,-0.0609954680670896,-0.0294679240703377,1.89784771830556e-08
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,39931,-0.0111414028077534,0.00842794450629196,-0.0276601740400856,0.0053773684245789,0.186200393685161
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,39931,-0.00340130028903795,0.00831618095002372,-0.0197010149510844,0.0128984143730085,0.682546674918332
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,39931,-0.027796447698013,0.00826736395901537,-0.0440004810576832,-0.0115924143383429,0.000775072749200183
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,39931,0.0346013456016297,0.00851720587036839,0.0179076220957077,0.0512950691075518,4.8775653833005e-05
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,39931,-0.0300973675174911,0.00803768465689043,-0.0458512294449963,-0.0143435055899858,0.000181360890641457
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,39931,-0.0179595405292737,0.00845703364985582,-0.0345353264829911,-0.00138375457555627,0.0337170190334918
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,39931,0.0373750739023392,0.00795973639867753,0.0217739905609312,0.0529761572437472,2.68131279057087e-06
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,39931,-0.0739177147815163,0.00890589533461524,-0.0913732696373622,-0.0564621599256705,1.1243179470228e-16
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,39931,0.0294847296649691,0.00826457032471782,0.0132861718285222,0.045683287501416,0.000361305957376283
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,39931,-0.0648675628796339,0.007955486399397,-0.080460316222452,-0.0492748095368158,3.78423874676727e-16
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,39931,0.0184045725425065,0.00831506966587188,0.0021070359973976,0.0347021090876154,0.0268840947182199
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,39931,0.0820922221626023,0.00823271979635069,0.0659560913617549,0.0982283529634496,2.37586572009351e-23
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,39931,-0.0841716194204527,0.00862848432665653,-0.1010834487007,-0.0672597901402059,2.02472766984257e-22
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,39931,0.0209183645129546,0.00808062691886161,0.00508033575198583,0.0367563932739234,0.00964241774996267
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,39931,-0.121138592902071,0.00810024409749651,-0.137015071333165,-0.105262114470978,3.14831208870325e-50
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,39931,0.0570306547925011,0.00802415309966716,0.0413033147171534,0.0727579948678487,1.23242447521023e-12
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,39931,0.112847059827094,0.00811962011265472,0.096932604406291,0.128761515247898,1.16421315635001e-43
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,39931,-0.0630085243892391,0.00822411221709267,-0.0791277843347407,-0.0468892644437374,1.94312187525868e-14
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,39931,0.0590623524448151,0.00827456516655188,0.0428442047183734,0.0752805001712568,9.88769192384016e-13
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,39926,-0.0860877290059602,0.00905057777717773,-0.103826861449229,-0.0683485965626918,2.13241181370071e-21
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,39926,0.017956830405304,0.00833464112029472,0.00162093380952634,0.0342927270010816,0.0312172469144805
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,39926,0.000462012745017008,0.00795456782452738,-0.0151289401910567,0.0160529656810907,0.953684481380286
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,39926,0.047248320380643,0.00956263889079157,0.0285055481546915,0.0659910926065945,7.85335605596611e-07
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,39926,0.120817955754079,0.00882317466690848,0.103524533406939,0.13811137810122,1.92840779448418e-42
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,39931,0.0893214288565132,0.00889722564494946,0.0718828665924122,0.106759991120614,1.20288853619952e-23
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,39931,-0.110837917750005,0.00906361800871192,-0.12860260904708,-0.0930732264529297,3.09351042904501e-34
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,39931,-0.10620887079612,0.00875454720307227,-0.123367783314141,-0.0890499582780981,1.00558023335216e-33
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,39931,-0.0407046811395269,0.00894968568969785,-0.0582460650913346,-0.0231632971877191,5.45102701949215e-06
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,39931,0.0944232553248707,0.00858445332668786,0.0775977268045625,0.111248783845179,4.84669911945231e-28
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,39931,0.0475814842843198,0.00900104254780659,0.0299394408906188,0.0652235276780207,1.26502843502126e-07
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,39931,-0.0735917549381184,0.00880050825771352,-0.0908407511232369,-0.0563427587529999,6.65440519733757e-17
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,39931,-0.0796073968370792,0.008413030488328,-0.0960969365942021,-0.0631178570799563,3.41737860531208e-21
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,39931,0.00972839269202328,0.00950135147466291,-0.00889425619831602,0.0283510415823626,0.305899964211527
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,39931,0.0838811612877892,0.0085426726161017,0.0671375229602298,0.100624799615349,1.07950686620426e-22
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,39931,-0.0079554772478103,0.00800868663981225,-0.0236525030618423,0.00774154856622171,0.320551432195534
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,39931,-0.04032188680983,0.00798135827583071,-0.0559653490304582,-0.0246784245892018,4.41982428980487e-07
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,39931,-0.0387925633354634,0.00783814595140095,-0.0541553294002093,-0.0234297972707175,7.52730575038857e-07
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,39931,0.00545468630396477,0.00868238539589573,-0.0115627890719909,0.0224721616799204,0.529850791940986
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,39931,0.0821952285215304,0.00874451195091256,0.0650559850977418,0.099334471945319,6.19628916055296e-21
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,51835,0.00104444840635056,0.00679771772938503,-0.0122790783432441,0.0143679751559452,0.877889245962086
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,51835,-0.0045208882347793,0.00665033617105281,-0.0175555471300428,0.0085137706604842,0.49663771194867
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,49870,-0.0013246128934255,0.00637677710828125,-0.0138230960256568,0.0111738702388058,0.835445706013242
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,49870,-0.00956940947802592,0.00688733483286634,-0.023068585750444,0.00392976679439211,0.164716581041656
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,49870,-0.00531784674630576,0.00685065528620015,-0.0187451311072581,0.00810943761464653,0.437606243194931
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,49870,-0.00724342061042541,0.00631946266263169,-0.0196295674291835,0.00514272620833271,0.251719515592368
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24009.Traffic intensity on the nearest road,51835,-0.0598593993373226,0.0247040479152833,-0.108279333251278,-0.0114394654233673,0.0153966733690334
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24010.Inverse distance to the nearest road,51835,-0.00143244572600869,0.00593747296014548,-0.0130698927278938,0.0102050012758765,0.809359164122919
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24011.Traffic intensity on the nearest major road,51835,-0.00154712928996161,0.00599724015195051,-0.0133017199877846,0.0102074614078614,0.796429223588949
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24012.Inverse distance to the nearest major road,51835,-0.00668539088953554,0.00608318549407101,-0.0186084344579147,0.00523765267884365,0.271779672559647
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24013.Total traffic load on major roads,51835,-0.0269293335903292,0.0170960803172434,-0.0604376510121263,0.00657898383146789,0.115227158184791
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24015.Sum of road length of major roads within 100m,51835,-0.0293857548699762,0.0165795464147312,-0.0618816658428493,0.0031101561028969,0.076337394386372
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,51835,0.0200778532008511,0.00681091310064806,0.00672846352358094,0.0334272428781213,0.00320210493769604
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,51835,0.0125946854320346,0.00680986240907559,-0.000752644889753514,0.0259420157538228,0.0643994742282679
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,51835,0.0218693876133606,0.00673885452383535,0.00866123274664335,0.0350775424800779,0.00117478083465751
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,51786,0.0474698321142888,0.00653177924288197,0.0346675447982401,0.0602721194303375,3.75748056878594e-13
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24020.Average daytime sound level of noise pollution,51835,-0.0136173534691369,0.00595409224113154,-0.0252873742617547,-0.00194733267651906,0.0221998783110005
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24021.Average evening sound level of noise pollution,51835,-0.0135794967825246,0.00595270046811999,-0.0252467897000398,-0.00191220386500947,0.0225421432045116
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24022.Average night-time sound level of noise pollution,51835,-0.0136283433981443,0.00595414364646461,-0.025298464945215,-0.00195822185107369,0.0220935174010324
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,51835,-0.0136330807398113,0.00595327812940523,-0.0253015058734456,-0.00196465560617707,0.0220280056124523
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,51835,-0.0136296279887929,0.0059534340208008,-0.0252983586695624,-0.00196089730802329,0.0220651330070007
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2405.Number of children fathered,36338,-0.0154652168300594,0.0182538877913772,-0.0512428369011588,0.02031240324104,0.396883932865751
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",48641,-0.01044512337796,0.00707819034932819,-0.0243183764626433,0.00342812970672323,0.140043302851914
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",48641,0.0078814594309017,0.00646185602257639,-0.00478377837334802,0.0205466972351514,0.222594124040657
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,"X24502.Water percentage, buffer 1000m",48641,-0.0150508615480591,0.0063203107875386,-0.0274386706916347,-0.0026630524044834,0.0172568980541493
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",48641,-0.00383872872003577,0.00669024004403787,-0.01695159920635,0.00927414176627846,0.566121609662227
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",48641,0.00306925544428076,0.00654116590064773,-0.00975142972098879,0.0158899406095503,0.638915472461149
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,"X24505.Water percentage, buffer 300m",48641,-0.00963852070753658,0.00634162677570789,-0.0220681091879241,0.00279106777285089,0.128553538992134
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",51923,-0.0166472895523961,0.00671046015252551,-0.0297997914513461,-0.00349478765344613,0.0131147146742185
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",51923,-0.00905814393118696,0.00633648443387406,-0.0214776534215801,0.0033613655592062,0.152865386699677
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24508.Distance (Euclidean) to coast,51923,0.0497957108610732,0.00605804124636541,0.037921950018197,0.0616694717039493,2.12594966553096e-16
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,28709,0.0082539340457925,0.0289496361792085,-0.0484873528654561,0.0649952209570411,0.775569312530185
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2704.Years since last cervical smear test,35712,0.00710050764877373,0.0172785995899673,-0.0267655475475621,0.0409665628451096,0.681122265793219
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2714.Age when periods started (menarche),39083,0.00562385267231783,0.0153893519368494,-0.024539277123907,0.0357869824685427,0.714789621151865
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2734.Number of live births,39563,-0.0170916643379701,0.0146753260701154,-0.0458553034353962,0.0116719747594561,0.244177131872857
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2744.Birth weight of first child,35644,-0.0367251346689749,0.0167940796838665,-0.0696415308493533,-0.00380873848859651,0.0287774244705765
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2754.Age at first live birth,33602,-0.0173110389721686,0.010064360158091,-0.0370371848820269,0.00241510693768969,0.0854580657531904
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2764.Age at last live birth,33580,-0.0189143810219028,0.0100891474192669,-0.0386891099636659,0.000860347919860366,0.0608604700424123
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2794.Age started oral contraceptive pill,37270,-0.00549601783103983,0.00990035500760812,-0.0249007136459517,0.0139086779838721,0.578812671144238
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2804.Age when last used oral contraceptive pill,36072,2.44472663300672e-05,0.0087447186756653,-0.0171152013379739,0.0171640958706341,0.997769434056605
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X2867.Age started smoking in former smokers,29379,0.0209175857804396,0.0133183318703736,-0.00518634468549261,0.0470215162463718,0.116336165536839
PLA2G4A,Cytosolic phospholipase A2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",36585,-0.0113067467771187,0.0198723839752861,-0.0502566193686795,0.0276431258144421,0.569388029091428
PLA2G4A,Cytosolic phospholipase A2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,36580,-0.00706208195380141,0.0220937323725341,-0.0503657974039682,0.0362416334963654,0.749245080008793
PLA2G4A,Cytosolic phospholipase A2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,36602,-0.0249403063319813,0.0226712418391391,-0.0693759403366939,0.0194953276727314,0.271315619946717
PLA2G4A,Cytosolic phospholipase A2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",36573,-0.000774480527187582,0.0221115227279635,-0.0441130650739959,0.0425641040196208,0.972059474474915
PLA2G4A,Cytosolic phospholipase A2,Mental health,X28739.Difficulty with standing for long periods,36613,-0.00237230196242906,0.0207980189498184,-0.0431364191040731,0.038391815179215,0.909188980419137
PLA2G4A,Cytosolic phospholipase A2,Mental health,X28740.Difficulty with taking care of household responsibilities,36637,0.0128321933011612,0.0231591790815747,-0.0325597976987253,0.0582241843010476,0.579529205512685
PLA2G4A,Cytosolic phospholipase A2,Mental health,X28741.Difficulty learning a new task,36541,0.00945133267865208,0.0260078395978579,-0.0415240329331494,0.0604266982904536,0.716309755152979
PLA2G4A,Cytosolic phospholipase A2,Mental health,X28742.Difficulty with joining in community activities,36103,0.00256228624221461,0.0249214527134078,-0.0462837610760647,0.0514083335604939,0.918111895799108
PLA2G4A,Cytosolic phospholipase A2,Mental health,X28743.Difficulty with being emotionally affected by health problems,36550,0.0138488734157578,0.0214689712440074,-0.0282303102224966,0.0559280570540123,0.518896985471739
PLA2G4A,Cytosolic phospholipase A2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,36635,-0.0463832531714574,0.0291857251113876,-0.103587274389777,0.0108207680468623,0.112029954573228
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,29224,-0.000915793184317255,0.0270349544764872,-0.0539043039582322,0.0520727175895977,0.97297855841602
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X2897.Age stopped smoking,29383,0.0308765130957228,0.0160727156090906,-0.000626009498094895,0.0623790356895404,0.0547766433293478
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,35244,-0.00479940148917022,0.0191501742994633,-0.0423337431161184,0.0327349401377779,0.802113053666461
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,35244,-0.0075060500836699,0.0205779654172876,-0.0478388623015536,0.0328267621342138,0.715296201966213
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,35244,0.0215587880519607,0.0695021701561295,-0.114665465454053,0.157783041557975,0.756423138639359
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,35244,0.0321818808132152,0.0679763222608732,-0.101051710818096,0.165415472444527,0.635917076953556
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,35244,0.125119114810149,0.073069650748175,-0.0180974006562745,0.268335630276572,0.0868637100825861
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,35244,0.117756507646877,0.0620929391367129,-0.0039456530610805,0.239458668354834,0.0579251064208726
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,35244,-0.0262511739166274,0.0284816548061644,-0.0820752173367096,0.0295728695034548,0.356711341556055
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,35244,-0.0354208441186585,0.0521051445587662,-0.13754692745384,0.0667052392165232,0.496647763012849
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29002.Recent lack of interest or pleasure in doing things,35173,-0.00904377972494847,0.0228470750128914,-0.0538240467502156,0.0357364873003186,0.692230740335011
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29003.Recent feelings of depression,35167,0.0132255760503027,0.0221251416626027,-0.0301397016083986,0.056590853709004,0.550010508221475
PLA2G4A,Cytosolic phospholipase A2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",35178,0.0260708987940669,0.0181150477529499,-0.00943459480171491,0.0615763923898487,0.150125870646657
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29005.Recent feelings of tiredness or low energy,35184,-0.00413071131880736,0.0183733006495486,-0.0401423805919225,0.0318809579543078,0.8221222685345
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29006.Recent poor appetite or overeating,35186,-0.0299090526256454,0.0242579068616225,-0.0774545500744256,0.0176364448231347,0.217615916895693
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29007.Recent feelings of inadequacy,35151,0.019450622120871,0.0236135327476585,-0.0268319020645396,0.0657331463062817,0.410123705161988
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29008.Recent trouble concentrating on things,35184,-0.00641318555600081,0.0235393545678424,-0.052550320508972,0.0397239493969703,0.785284644853906
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,35175,-0.114628158656358,0.0418468472313937,-0.196647979229889,-0.0326083380828263,0.00616796465035571
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29010.Recent thoughts of suicide or self-harm,35110,0.0193241816070262,0.0459189595543976,-0.070676979119593,0.109325342333645,0.673885580059716
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29038#0.Substances taken for depression_None of options listed,32756,-0.0324451722151489,0.0370168972027849,-0.104998290732607,0.0401079463023096,0.38078397194416
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),32756,-0.116521888055397,0.0654076162582994,-0.244720815921664,0.0116770398108695,0.0748693539238972
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),32756,-0.0368566197333951,0.0361214584292345,-0.107654678254695,0.0339414387879046,0.307589068636181
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),32756,-0.0311587447225799,0.103913904359886,-0.234829997267957,0.172512507822798,0.764297402052386
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),32756,-0.132595968687391,0.0618181404897456,-0.253759524047292,-0.0114324133274895,0.0319849457184984
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),32756,-0.0168563084554755,0.06727393684218,-0.148713224666148,0.115000607755197,0.802158363326486
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),32756,-0.0393306401945127,0.0754517646248556,-0.18721609885923,0.108554818470204,0.602192605941285
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),32756,0.079656252188015,0.0927362930801718,-0.102106882249122,0.261419386625152,0.390388787238836
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),32756,-0.0615732623750661,0.07375124164136,-0.206125695992132,0.0829791712419994,0.403809026639145
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,32756,-0.0498049599826613,0.0373958548779502,-0.123100835543444,0.023490915578121,0.182949839432008
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,32756,-0.0593218571098572,0.0547075758097629,-0.166548705696993,0.047904991477278,0.278241482186652
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,32756,0.0407540480221475,0.0855422623475794,-0.126908786179108,0.208416882223403,0.633786861503969
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,32756,0.164123487293427,0.107976459739204,-0.0475103737954125,0.375757348382266,0.128548217154579
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,32756,0.0247089953791406,0.0652026114683691,-0.103088123098863,0.152506113857144,0.704728733046249
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,32756,0.0437038741013637,0.111254098126135,-0.174354158225862,0.261761906428589,0.694454944198016
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,32756,0.0897404061524782,0.106190274769702,-0.118392532396138,0.297873344701095,0.398082967263023
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,32756,-0.0974932636654464,0.0569644500285138,-0.209143585721333,0.0141570583904407,0.0870282177613637
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,32756,0.0890527880653043,0.0555802872806458,-0.0198845750047614,0.19799015113537,0.109138733596076
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,32756,-0.0252869268248837,0.0797477298386284,-0.181592477308595,0.131018623658828,0.751185425476984
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29058.Recent feelings or nervousness or anxiety,35005,0.0193837774531259,0.0211530284149878,-0.0220761582402502,0.060843713146502,0.35949822792497
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29059.Recent inability to stop or control worrying,35011,0.0178721665151659,0.0221455525088056,-0.0255331164020931,0.0612774494324248,0.419665341303655
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29060.Recent worrying too much about different things,35002,0.0334209819836903,0.020296050231653,-0.0063592764703495,0.0732012404377302,0.0996532395347801
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29061.Recent trouble relaxing,35009,0.000885140967159605,0.0212223156168052,-0.0407105976417785,0.0424808795760977,0.966732199855031
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29062.Recent restlessness,35013,0.00981743811785209,0.0298287798161532,-0.0486469703218082,0.0682818465575124,0.742066351924673
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29063.Recent easy annoyance or irritability,34995,0.0140893591684544,0.0214936075047891,-0.0280381115409323,0.0562168298778411,0.512150464398829
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29064.Recent feelings of foreboding,34987,-0.00798116770108976,0.0246436744773581,-0.0562827696767116,0.0403204342745321,0.746048049448954
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,32756,-0.00876853130475799,0.0373160447923169,-0.081907979097699,0.0643709164881831,0.814229516987773
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,32756,-0.122364342705935,0.0616682267829103,-0.243234067200439,-0.00149461821143092,0.0472601663164135
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',32756,-0.141856262759938,0.0801312323301159,-0.298913478126965,0.0152009526070892,0.0767115411042158
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,32756,-0.0599032513332463,0.0894940297581962,-0.235311549659311,0.115505046992818,0.503286598661072
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29065#2.Symptoms of panic attack_Sweating,32756,0.00665695279648509,0.0560922087699045,-0.103283776392528,0.116597681985498,0.905532558181622
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,32756,-0.0593267274888374,0.060454445708429,-0.177817441077358,0.0591639860996835,0.326448840991229
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,32756,-0.0470204152841174,0.0607894564477147,-0.166167749921638,0.0721269193534033,0.439249312903289
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,32756,-0.0334093956049941,0.0547699737718379,-0.140758544197796,0.0739397529878082,0.541880876371167
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,32756,-0.106851949333601,0.0731605375049077,-0.25024660284322,0.0365427041760178,0.144184327531041
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29076.Felt loved as a child,34960,0.00145732115111736,0.0189700411459443,-0.0357239594949334,0.0386386017971681,0.938766338911849
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29077.Physically abused by family as a child,34964,-0.00744785719506029,0.0242978821366953,-0.055071706182983,0.0401759917928625,0.759212298651411
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29078.Felt hated by family member as a child,34950,0.00367418854657936,0.0248969515891717,-0.0451238365681971,0.0524722136613558,0.882680206623822
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29079.Sexually molested as a child,34868,0.0266772563676871,0.034035804605284,-0.0400329206586696,0.0933874333940438,0.433174468051543
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29080.Someone to take to doctor when needed as a child,34948,0.0052719714413526,0.0285157168658374,-0.0506188336156888,0.061162776498394,0.853326933614938
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,34950,-0.00311809244717455,0.0336150515902832,-0.0690035935641296,0.0627674086697805,0.926096844178334
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,34889,0.0226677887386533,0.0266964073586042,-0.0296571696842109,0.0749927471615175,0.39584680637941
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,34958,0.0131761626281018,0.0295666183115919,-0.0447744092626183,0.0711267345188219,0.655863687978048
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,34919,0.0695907595287399,0.0419759571249184,-0.0126821164361001,0.15186363549358,0.0973716907942695
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,34918,0.070483585987244,0.0409111347691228,-0.00970223816023669,0.150669410134725,0.0849443334558144
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29086.Experienced a violent or sexual assault,34957,-0.0258503967616174,0.0326296963566364,-0.0898046016206247,0.03810380809739,0.428240435209038
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29087.Experienced a life-threatening injury or illness,34965,-0.00539069355720272,0.02294851758188,-0.0503697880176874,0.039588400903282,0.814287745977407
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29088.Experienced a marital separation or divorce,34967,-0.0278226756484859,0.0205118476266519,-0.0680258969967236,0.0123805456997518,0.174993219237461
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29089.Experienced the death of a spouse or partner,34978,-0.00754233589115271,0.0327667495271782,-0.0717651649644219,0.0566804931821165,0.817954110369438
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,34964,-0.00637945118367079,0.0254404792483226,-0.056242790510383,0.0434838881430414,0.802004412144835
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29091.Frequency of drinking alcohol,34972,-0.0443270512176556,0.0172090175110021,-0.0780567255392197,-0.0105973768960915,0.0100135428972776
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,33855,-0.0200245081971731,0.0191116995017816,-0.0574834392206649,0.0174344228263188,0.294773720909268
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,33868,-0.033105446362838,0.0191328200599116,-0.0706057736802648,0.00439488095458872,0.0836081994931913
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29104.Ever used cannabis,34958,-0.0209351300967259,0.0225602462229404,-0.0651532126936891,0.0232829525002372,0.353445653931052
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29108.Ever thought that life not worth living,34911,0.0119888518096969,0.020894595196312,-0.0289645547750747,0.0529422583944685,0.566129950044807
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29109.Ever contemplated self-harm,34929,0.0240524094782368,0.0271610030091461,-0.0291831564196894,0.0772879753761631,0.375879635685521
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29111.Ever self-harmed,34947,0.0274752225986629,0.0426832760805759,-0.0561839985192658,0.111134443716592,0.519783339264364
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,34953,-0.0168263063324738,0.0295081411504181,-0.0746622629872934,0.0410096503223457,0.568536041588089
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,33435,0.0398423772544958,0.0760826351794548,-0.109279587697236,0.188964342206227,0.600518525220068
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,33435,0.00721126310013422,0.0592767720631196,-0.10897121014358,0.123393736343849,0.903175508966712
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,33435,0.05618889316298,0.0620683393702909,-0.0654650520027902,0.17784283832875,0.365342689340417
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,33435,0.0245807653734279,0.082900983745047,-0.137905162766864,0.18706669351372,0.766848953310596
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,34945,-0.0342577433828908,0.0192204728058698,-0.0719298700823957,0.00341438331661405,0.0747184050552086
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X29153.Pain or discomfort today,34960,-0.00158400617462179,0.0184560382806976,-0.037757841204789,0.0345898288555455,0.931606362199655
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29154.Anxiety or depression today,34960,-0.00290512162029116,0.0226582616226267,-0.0473153144006395,0.0415050711600572,0.897981411361564
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29166.Frequency of confiding in someone close,34721,-0.000909171752383358,0.017927155300515,-0.0360463961413928,0.0342280526366261,0.959553731335257
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,34925,0.0241042452089262,0.0199399062437904,-0.0149779710289029,0.0631864614467553,0.2267484374963
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,34925,-0.0284306130505321,0.0198101011120002,-0.0672584112300525,0.0103971851289883,0.151270516594185
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,34925,-0.0122968185957365,0.0246595793229955,-0.0606295940688077,0.0360359568773346,0.618026761514738
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,34925,0.0386241124393724,0.0293708575115204,-0.0189427682832076,0.0961909931619525,0.188520736776291
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,34925,-0.0912681849742824,0.0452908145372368,-0.180038181467266,-0.00249818848129828,0.0439121460513613
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,34925,-0.00964664403038366,0.0214241243231211,-0.051637927703701,0.0323446396429337,0.652524469187247
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,34924,0.0180380661974526,0.0234596200950975,-0.0279427891889385,0.0640189215838438,0.441969993295384
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,34924,-0.0294604630109388,0.0332030684270097,-0.0945384771278778,0.0356175511060002,0.374946736535428
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,34924,-0.019238471734053,0.0532981758960097,-0.123702896490232,0.0852259530221261,0.71813677163955
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,34924,0.0392462188045131,0.0528237344855958,-0.0642883007872547,0.142780738396281,0.457518268020389
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,34924,-0.0599130535059549,0.0701442724853613,-0.197395827577263,0.0775697205653532,0.393045721500356
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,34924,-0.0380606533719845,0.0351744094153974,-0.107002495826164,0.0308811890821945,0.279251573771015
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29171.Frequency of feeling 'in tune' with people,34739,0.0149482561973681,0.0219167125670832,-0.028008500434115,0.0579050128288512,0.49522294194614
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29172.Freuency of feeling that lacks companionship,34874,0.0242025197601789,0.020142962600388,-0.0152776869365815,0.0636827264569393,0.229568706169766
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29173.Frequency of feeling left out,34828,0.00302173079470267,0.020647891682011,-0.0374481369020389,0.0434915984914443,0.883651156397686
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29174.Frequency of feeling isolated from others,34863,0.00454821019392751,0.0213369125092402,-0.0372721383241832,0.0463685587120382,0.831204876075696
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29175.Tendency to bounce back quickly after hard times,34943,0.0118116984803812,0.0178635941104932,-0.0232009459761855,0.0468243429369479,0.508487398303908
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29176.Ability to make it through stressful events,34943,-0.00599770740320911,0.0174954640777388,-0.0402888169955772,0.028293402189159,0.731744148851505
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29177.Quick recovery from stressful events,34943,0.0145127471039534,0.0177368817036014,-0.0202515410351053,0.0492770352430121,0.413246734430369
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29178.Hard to snap back when something bad happens,34943,-0.0201057609394794,0.017602060752222,-0.0546058000138345,0.0143942781348756,0.253379355797921
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29179.Comes through difficult times with little trouble,34943,-0.00984231754883893,0.0177882307873895,-0.0447072498921224,0.0250226147944445,0.58006572190208
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29180.Tendency to take a long time to get over setbacks,34943,-0.0152555140312399,0.0176703291642212,-0.0498893591931134,0.0193783311306336,0.387968870151563
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29181.General happiness,34875,0.0123335177326485,0.0183557579291233,-0.0236437678084332,0.0483108032737302,0.501651607925746
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29182.Belief that own life is meaningful,34773,0.00972824837122778,0.0183066850231555,-0.026152854274157,0.0456093510166126,0.595149565848099
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,28918,0.0485940864933602,0.0262627178296744,-0.00288084045280168,0.100069013439522,0.0643276267772859
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2946.Father's age,34133,-0.000207754375578487,0.0146327666650731,-0.0288879770391217,0.0284724682879647,0.988672381018094
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2966.Age high blood pressure diagnosed,29081,0.0115728814881468,0.0232696803878784,-0.0340356920720948,0.0571814550483884,0.618972111034289
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30000.White blood cell (leukocyte) count,51352,0.0787622361877777,0.00621174816279666,0.0665872097886962,0.0909372625868591,9.7294025654723e-37
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,51352,0.0200946813713563,0.00734415391962925,0.005700139688883,0.0344892230538297,0.00622032322371251
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30020.Haemoglobin concentration,51352,-0.0252503888629317,0.00783818191777977,-0.04061322542178,-0.00988755230408332,0.00127687696874936
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30030.Haematocrit percentage,51352,0.00127870477969075,0.00767512503542729,-0.0137645402897467,0.0163219498491282,0.867683050975536
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30040.Mean corpuscular volume,51352,-0.0251467886170878,0.00622577000087661,-0.0373492978188059,-0.0129442794153696,5.37919463870231e-05
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,51351,-0.0496891695659297,0.00623537029559241,-0.0619104953452908,-0.0374678437865685,1.66226565070443e-15
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,51351,-0.0569995578459997,0.00607470824638666,-0.0689059860089176,-0.0450931296830819,6.88427236966104e-21
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,51352,0.03191751811273,0.0059390455330541,0.020276988867944,0.043558047357516,7.75561746849342e-08
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30080.Platelet count,51352,0.360928548088363,0.00589588807155314,0.349372607468119,0.372484488708607,0
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30090.Platelet crit,51352,0.325027993350846,0.00613368617639346,0.313005968445115,0.337050018256577,0
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,51352,-0.165969607713049,0.0059726586092702,-0.177676018587218,-0.154263196838879,1.25080893156614e-167
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30110.Platelet distribution width,51352,-0.10146037757523,0.00596391765833679,-0.11314965618557,-0.0897710989648902,1.42411424836376e-64
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30120.Lymphocyte count,51316,0.0516639758564231,0.0063384256390386,0.0392406616039074,0.0640872901089387,3.76416456758704e-16
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30130.Monocyte count,51316,0.0446669435074045,0.00631540641373754,0.0322887469364789,0.0570451400783301,1.55591180337306e-12
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30140.Neutrophill count,51316,0.0656036445312238,0.00615840368941659,0.0535331732999673,0.0776741157624803,1.90776436780837e-26
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30150.Eosinophill count,51316,0.0489197470365462,0.00604931103412229,0.0370630974096665,0.0607763966634259,6.37409717997477e-16
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30160.Basophill count,51316,0.116862661960837,0.0123682778166251,0.092620837440252,0.141104486481422,3.69850373665463e-21
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30170.Nucleated red blood cell count,51316,-0.0946268054582997,0.0560868442029077,-0.204557020095999,0.0153034091793995,0.0915862624644535
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30180.Lymphocyte percentage,51316,-0.0185529326481043,0.00622685015089347,-0.0307575589438555,-0.00634830635235306,0.00288966883545684
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30190.Monocyte percentage,51316,-0.0123704230318154,0.00624255404269529,-0.0246058289554982,-0.000135017108132634,0.0475307916481729
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30200.Neutrophill percentage,51316,0.0132006370149374,0.00613348960754002,0.00117899738415895,0.0252222766457158,0.0313884890142803
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30210.Eosinophill percentage,51316,0.0233518253306211,0.00597776912792858,0.011635397839881,0.0350682528213611,9.38882899059987e-05
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30220.Basophill percentage,51316,0.00130400545387671,0.00594341596641483,-0.0103450898402964,0.0129531007480498,0.826337481126117
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30230.Nucleated red blood cell percentage,51315,-0.0958565426916019,0.0561695148407321,-0.205948791779437,0.0142357063962329,0.0879155205120478
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30240.Reticulocyte percentage,50865,0.0368978993984381,0.00639134506545255,0.0243708630701511,0.0494249357267251,7.86760759624393e-09
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30250.Reticulocyte count,50865,0.0406786091992816,0.00655197350618126,0.0278367411271664,0.0535204772713969,5.42352730232907e-10
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30260.Mean reticulocyte volume,50865,-0.013475125075327,0.00618354296532248,-0.0255948692873591,-0.00135538086329498,0.0293260478580244
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30270.Mean sphered cell volume,50865,-0.00755565230329969,0.00620670961622634,-0.0197208031511033,0.00460949854450394,0.223486963586534
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30280.Immature reticulocyte fraction,50865,0.0162512468799205,0.0064498906365139,0.00360946123235324,0.0288930325274877,0.0117540170235101
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,50865,0.0338017443237504,0.00653945685296632,0.0209844088919364,0.0466190797555644,2.37162106322675e-07
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30300.High light scatter reticulocyte count,50865,0.0365842765774823,0.00665097116840855,0.0235483730874016,0.0496201800675631,3.8194902113813e-08
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30500.Microalbumin in urine,32075,0.00701552080485243,0.0113669927883113,-0.0152637850602378,0.0292948266699426,0.53713077909827
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,51465,-0.00671212222263695,0.00637329222046994,-0.019203774974758,0.00577953052948412,0.29227503165704
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30520.Potassium in urine,51401,-0.00343997147203565,0.00590169878901864,-0.0150073010985122,0.00812735815444088,0.559980080098727
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30530.Sodium in urine,51406,-0.0133094419257559,0.00613953018301003,-0.0253429210844556,-0.00127596276705627,0.0301803544293383
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30600.Albumin,48671,0.0447649827405914,0.00660444073757721,0.0318202788949401,0.0577096865862428,1.24569960027284e-11
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30610.Alkaline phosphatase,50943,0.0577461644306014,0.00622591287518561,0.0455433751952376,0.0699489536659652,1.9021422000034e-20
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30620.Alanine aminotransferase,50933,0.027543908342325,0.0065844229229478,0.0146384394133474,0.0404493772713027,2.88348789000717e-05
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30630.Apolipoprotein A,48535,-0.00333795453084615,0.0072167808852718,-0.0174828450659789,0.0108069360042866,0.64370767036714
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30640.Apolipoprotein B,50778,0.0819350282379298,0.00630676001100609,0.0695737786163578,0.0942962778595017,1.78210864710894e-38
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30650.Aspartate aminotransferase,50853,0.00986171230267273,0.00618214334734953,-0.00225528865813235,0.0219787132634778,0.110680772316637
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30660.Direct bilirubin,46729,-0.0439823587137182,0.00672875638416217,-0.057170721226676,-0.0307939962007603,6.43123264953022e-11
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30670.Urea,50934,-0.0171434248245437,0.00649352842363812,-0.0298707405348745,-0.00441610911421301,0.0082934350751571
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30680.Calcium,48666,0.0915706251090686,0.0064126304280259,0.0790018694701378,0.104139380747999,4.45913180888092e-46
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30690.Cholesterol,50948,0.0812072282824327,0.00648612482481462,0.068494423625796,0.0939200329390693,7.28203415295459e-36
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30700.Creatinine,50937,-0.0446297022062798,0.00785208630421196,-0.0600197913625353,-0.0292396130500244,1.33085773402068e-08
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30710.C-reactive protein,50863,0.0881860400868302,0.00675207595812388,0.0749519712089074,0.101420108964753,7.25470565287112e-39
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30720.Cystatin C,50941,0.0302298560622623,0.00725093720898996,0.016018019132642,0.0444416929918826,3.06759854361116e-05
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30730.Gamma glutamyltransferase,50933,0.0718473075824325,0.00670248970906206,0.0587104277526709,0.0849841874121942,9.33081896897431e-27
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30740.Glucose,48631,0.0221404918209465,0.00655570341427122,0.00929131312897489,0.0349896705129181,0.000733172312043375
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),50707,0.033132121073922,0.00658628297759695,0.020223006437832,0.0460412357100121,4.92423299683932e-07
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30760.HDL cholesterol,48649,-0.0284101707837905,0.00762990830448369,-0.0433647910605785,-0.0134555505070025,0.000196893609567415
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30770.IGF-1,50821,-0.00677637146590387,0.00640597327804496,-0.019332079090872,0.00577933615906426,0.290146647850433
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30780.LDL direct,50889,0.0786995587294036,0.00641748698204728,0.0661212842445909,0.0912778332142163,1.76100545104501e-34
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30790.Lipoprotein A,45532,-0.00621402756037606,0.00679319777304061,-0.0195286951955357,0.00710064007478353,0.360336938970491
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30810.Phosphate,48605,0.0484028562460423,0.00644088359350688,0.0357787244027689,0.0610269880893158,5.88650392289368e-14
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30830.SHBG,48421,-0.0564718838462209,0.00747265329051418,-0.0711182842956287,-0.0418254833968131,4.26407534447691e-14
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30840.Total bilirubin,50842,-0.0600958959163446,0.00630112011750728,-0.0724460913466589,-0.0477457004860303,1.58463604193379e-21
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30850.Testosterone,48768,-0.0117649401213986,0.0106418667238656,-0.0326229989001752,0.00909311865737793,0.268939166749764
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30860.Total protein,48650,0.122926107796967,0.00648319992660276,0.110219035940825,0.135633179653108,1.31926482907253e-79
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30870.Triglycerides,50924,0.106123680846366,0.00645158451280095,0.0934785752012761,0.118768786491456,1.67088811584408e-60
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30880.Urate,50912,0.03727264804147,0.00779813951048839,0.0219882946009128,0.0525570014820273,1.76491980444765e-06
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30890.Vitamin D,49839,-0.0130734486938672,0.00675187276438021,-0.0263071193120524,0.00016022192431801,0.0528454732599597
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X3137.Number of measurements made,49965,-0.00910075539584682,0.0140682429114623,-0.036674511502313,0.0184730007106193,0.517701937162555
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X3143.Ankle spacing width,39973,-0.0301449004010961,0.0112846381645345,-0.0522627912035837,-0.00802700959860844,0.00756290916686914
PLA2G4A,Cytosolic phospholipase A2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",39972,-0.00172426329703682,0.00865656483805516,-0.0186911303796249,0.0152426037855513,0.842120055389603
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X3146.Speed of sound through heel,39973,-0.0108746285791514,0.00840778833578779,-0.0273538937172954,0.00560463655899271,0.195891491320895
PLA2G4A,Cytosolic phospholipase A2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",39973,-0.00806366588430069,0.00849062255416287,-0.0247052860904599,0.00857795432185854,0.342271672017822
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X3148.Heel bone mineral density (BMD),39963,-0.00755163164132882,0.00850036170842044,-0.0242123405898329,0.00910907730717523,0.374344569310809
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X3526.Mother's age at death,35371,0.0040194560764763,0.0111457071480568,-0.0178261299337151,0.0258650420866677,0.718384038139928
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X3581.Age at menopause (last menstrual period),30422,-0.0283087175482838,0.0152153049918119,-0.058130715332235,0.00151328023566747,0.0628535420632119
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",30368,-0.0162161521877022,0.0142646144833556,-0.0441747965750792,0.0117424921996748,0.255659700828546
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4100.Ankle spacing width (left),32817,-0.0125639132107679,0.0143132188592552,-0.0406178221749081,0.0154899957533723,0.380084541859151
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),32816,-0.0247049819153386,0.0110580256411947,-0.0463787121720803,-0.00303125165859697,0.0254996069476355
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4103.Speed of sound through heel (left),32817,-0.0201478792523711,0.0107850743532483,-0.0412866249847377,0.000990866479995578,0.0617771165075817
PLA2G4A,Cytosolic phospholipase A2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",32817,-0.0223357793426804,0.0108833184459964,-0.0436670834968333,-0.00100447518852751,0.0401700064671433
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4105.Heel bone mineral density (BMD) (left),32809,-0.0205736478957001,0.0109106109415139,-0.0419584453410674,0.000811149549667219,0.0593738240181889
PLA2G4A,Cytosolic phospholipase A2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",32817,-0.022377307286557,0.0108834271250874,-0.0437088244517283,-0.00104579012138569,0.0398027406865249
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4119.Ankle spacing width (right),32809,0.0103212949730839,0.014048419302952,-0.0172136068607021,0.03785619680687,0.462544883186911
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),32809,-0.00823251253910087,0.0111534658123287,-0.030093305531265,0.0136282804530633,0.460465442998738
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4122.Speed of sound through heel (right),32809,-0.0112125454334102,0.0108439456856871,-0.0324666789773569,0.0100415881105365,0.301168173994055
PLA2G4A,Cytosolic phospholipase A2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",32809,-0.0108135205794343,0.0109555687153925,-0.0322864352616037,0.010659394102735,0.323652577169987
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4124.Heel bone mineral density (BMD) (right),32800,-0.010518240228099,0.0109857264666654,-0.0320502641027632,0.0110137836465652,0.338368063623806
PLA2G4A,Cytosolic phospholipase A2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",32809,-0.0108165513024975,0.0109556084427075,-0.0322895438502041,0.0106564412452091,0.323518745591107
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4194.Pulse rate,33113,0.0518072616671545,0.0103873612886249,0.0314480335414496,0.0721664897928594,6.22680140750815e-07
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4195.Pulse wave reflection index,33113,-0.0329704505432894,0.0101637578365467,-0.0528914159029209,-0.0130494851836579,0.00118313946192199
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4196.Pulse wave peak to peak time,33108,-0.00403098629907576,0.0109163305083455,-0.0254269940954329,0.0173650214972814,0.711940882857966
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4198.Position of the pulse wave peak,33113,-0.000904015377611599,0.0104316030062737,-0.0213499572699081,0.0195419265146849,0.930942682492927
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4199.Position of pulse wave notch,33113,0.0319905901613889,0.0102716161182177,0.0118582225696822,0.0521229577530957,0.00184841634127675
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4200.Position of the shoulder on the pulse waveform,33113,0.00669209233726586,0.010684809181183,-0.0142501336578528,0.0276343183323845,0.53112158544463
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4269.Number of triplets attempted (left),32982,-0.062728493874701,0.0678606308512247,-0.195735330343101,0.0702783425936993,0.355316950795009
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4270.Volume level set by participant (left),32894,-0.0379835696484498,0.0201038570609818,-0.0773871294879741,0.00141999019107447,0.0588746369056799
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4276.Number of triplets attempted (right),32990,-0.121610885190208,0.0658690738461575,-0.250714269928676,0.00749249954826095,0.0648880701676218
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4277.Volume level set by participant (right),32888,-0.00707892083186716,0.0199890357209791,-0.0462574308449862,0.0320995891812519,0.723242100181193
PLA2G4A,Cytosolic phospholipase A2,Cognitive function,X4288.Time to answer,33146,0.0399911868556396,0.0117109955822286,0.0170376355144715,0.0629447381968077,0.000640923518367975
PLA2G4A,Cytosolic phospholipase A2,Cognitive function,X4290.Duration screen displayed,33146,-0.00702373837470259,0.0104361502504257,-0.0274785928655369,0.0134311161161317,0.500951282761448
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X46.Hand grip strength (left),52175,-0.00813207580857641,0.00849088870389069,-0.0247742176682022,0.00851006605104935,0.33820134196904
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X47.Hand grip strength (right),52154,-0.00737163320414563,0.00841437784695946,-0.0238638137841862,0.00912054737589492,0.380996239269654
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X48.Waist circumference,52234,0.0585912426191027,0.0133082409446884,0.0325070903675135,0.0846753948706918,1.07337574488581e-05
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X4803.Tinnitus,32933,-0.0235812817868197,0.0248210263896403,-0.0722304935105146,0.0250679299368752,0.342110817040943
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X4825.Noisy workplace,33070,0.0270235831677991,0.0271717361627304,-0.0262330197111525,0.0802801860467508,0.319982510193297
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X4836.Loud music exposure frequency,33008,0.015582905273953,0.0294015177139113,-0.0420440694453131,0.0732098799932191,0.596122417611978
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X49.Hip circumference,52230,-0.0276970191908702,0.0105091511831638,-0.0482949555098712,-0.00709908287186922,0.00840555499118611
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X50.Standing height,52206,-0.0392373232375998,0.00834752760130046,-0.0555984773361487,-0.0228761691390509,2.60779550311966e-06
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X5057.Number of older siblings,32276,0.000605064103106702,0.0210205068011299,-0.040595129227108,0.0418052574333214,0.977037171160056
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X51.Seated height,52065,-0.0309947936716947,0.00774430900474614,-0.0461736393209971,-0.0158159480223923,6.2898672951027e-05
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5181.Ever had eye surgery,30125,0.0273547462478035,0.0539423845788219,-0.0783723275266874,0.133081820022294,0.612095185969257
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5186.Duration visual-acuity screen displayed (right),30110,0.0167640594052846,0.0126037199515063,-0.00793923169966769,0.0414673505102368,0.183537740884866
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5188.Duration visual-acuity screen displayed (left),30109,0.0204166203027841,0.0124843070825804,-0.00405262157907347,0.0448858621846417,0.102019202914691
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5190.Duration at which refractometer first shown (right),30053,0.0146971869714067,0.0123452154924714,-0.00949943539383727,0.0388938093366506,0.233888945357566
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5193.Duration at which refractometer first shown (left),30052,0.0187630962592933,0.0123689309526118,-0.00548000840782576,0.0430062009264124,0.129329408877875
PLA2G4A,Cytosolic phospholipase A2,Eye measures,"X5199.logMAR, initial (right)",30086,0.0227171680427375,0.0253219555987383,-0.0269138649307896,0.0723482010162645,0.369682517837006
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5200.Final number of letters displayed (right),30086,0.0799397514151442,0.193210433636509,-0.298752698512412,0.458632201342701,0.679075499925506
PLA2G4A,Cytosolic phospholipase A2,Eye measures,"X5201.logMAR, final (right)",30032,0.0111175194612906,0.0119518447296812,-0.0123080962088846,0.0345431351314658,0.352307668574124
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5202.Number of rounds to result (right),30086,-0.0106600102735629,0.0240703347074329,-0.0578378663001314,0.0365178457530055,0.657875747818587
PLA2G4A,Cytosolic phospholipase A2,Eye measures,"X5206.logMAR, initial (left)",30083,0.0209507638375145,0.0250364261761538,-0.0281206314677469,0.0700221591427759,0.402730793768142
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5207.Final number of letters displayed (left),30083,0.130835510609103,0.175533722170416,-0.213210584844913,0.474881606063118,0.45608332595351
PLA2G4A,Cytosolic phospholipase A2,Eye measures,"X5208.logMAR, final (left)",30034,0.00346384602337773,0.0119835800848904,-0.0200239709430074,0.0269516629897628,0.772553318101305
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5209.Number of rounds to result (left),30080,0.042180928540295,0.0242299706926633,-0.00530981401732503,0.089671671097915,0.0817580775365838
PLA2G4A,Cytosolic phospholipase A2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",29837,0.00508503594462904,0.0124648903830103,-0.0193461492060712,0.0295162210953293,0.683325942983115
PLA2G4A,Cytosolic phospholipase A2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",29837,0.0261425292151552,0.0122338820892947,0.00216412032013754,0.0501209381101729,0.0326469617670198
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5256.Corneal hysteresis (right),29837,0.0283850466822174,0.0125424645785429,0.00380181610827328,0.0529682772561616,0.0236642866585695
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5257.Corneal resistance factor (right),29837,0.0352311691348059,0.0123041711352322,0.0111149937097508,0.0593473445598611,0.00420643938255644
PLA2G4A,Cytosolic phospholipase A2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",29816,0.0120752982628776,0.0125736757045072,-0.0125691061179565,0.0367197026437116,0.336911323493546
PLA2G4A,Cytosolic phospholipase A2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",29816,0.0128743214841948,0.012279823409995,-0.0111941323993953,0.036942775367785,0.294491095465245
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5264.Corneal hysteresis (left),29816,0.00623587207889974,0.0125074866732197,-0.0182788018006109,0.0307505459584104,0.618099941067687
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5265.Corneal resistance factor (left),29816,0.0105296338342558,0.0122553322749853,-0.0134908174247154,0.034550085093227,0.390271407412609
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,29931,0.131636421143892,0.0965536561587636,-0.0576087449272842,0.320881587215069,0.172822813943928
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",52133,-0.011278721148185,0.0361940126484452,-0.0822189859391376,0.0596615436427676,0.755332829015633
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",52133,-0.0369652968415756,0.0404221844871447,-0.116192778436379,0.0422621847532281,0.360472252658396
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",52133,0.0443038669385349,0.0955000487318958,-0.142876228575981,0.231483962453051,0.642712503506294
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",52133,-0.0761143519688631,0.0167490490155947,-0.108942488039429,-0.0432862158982975,5.53202604166562e-06
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",52133,0.0588746736715429,0.0150097752402686,0.0294555142006165,0.0882938331424693,8.78702573977772e-05
PLA2G4A,Cytosolic phospholipase A2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",37925,-0.0168092650034272,0.0169082258093317,-0.0499493875897174,0.016330857582863,0.320168321406132
PLA2G4A,Cytosolic phospholipase A2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",37925,-0.0700566930821912,0.0598320140282089,-0.187327440577481,0.0472140544130982,0.241662924859204
PLA2G4A,Cytosolic phospholipase A2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",37925,0.00137346684042301,0.02873655970608,-0.0549501901834939,0.0576971238643399,0.96188021767851
PLA2G4A,Cytosolic phospholipase A2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",37925,0.0252721329665948,0.0182492520504942,-0.0104964010523739,0.0610406669855635,0.166126064801548
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,52217,0.00033344264055548,0.0340131855088824,-0.0663324009568541,0.0669992862379651,0.99217826487553
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,52217,0.00033344264055548,0.0340131855088824,-0.0663324009568541,0.0669992862379651,0.99217826487553
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),52217,-0.0078228233826037,0.0248921034799812,-0.0566113462033669,0.0409656994381595,0.753318841755679
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',52217,-0.0366673425418895,0.0386085307802232,-0.112340062871127,0.0390053777873479,0.342261997510737
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),52217,0.137399333109867,0.0951480266229486,-0.0490907990711128,0.323889465290846,0.148733519546664
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),52217,0.180565537039002,0.0661983574931209,0.0508167563524848,0.310314317725519,0.00638277035538717
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,52217,0.18982330863884,0.101894454687326,-0.00988982254831808,0.389536439825999,0.0624809662593934
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,52132,-0.0217270331266248,0.0190129393278193,-0.0589923942091506,0.015538327955901,0.253152152554228
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,52132,0.0249010959048146,0.0328052615847035,-0.0393972168012043,0.0891994086108335,0.447824196533162
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,52132,0.0149251762833774,0.0159974557379495,-0.0164298369630037,0.0462801895297585,0.350842457102641
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,52132,0.0325991571667657,0.0301642547782125,-0.0265227821985309,0.0917210965320622,0.279830257137117
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,52132,0.0168801699645784,0.0262066050541089,-0.0344847759414749,0.0682451158706318,0.519503552241413
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,52132,0.00991941714332248,0.0212912958424374,-0.0318115227078548,0.0516503569944998,0.641297313297544
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,30121,-0.137273418210604,0.0554040341677162,-0.245865325179328,-0.0286815112418801,0.0132501852112906
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,30121,-0.119171543336142,0.04801187842174,-0.213274825042752,-0.0250682616295314,0.0130861228473778
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,30121,0.0194895017807491,0.0597042301882508,-0.0975307893882224,0.136509792949721,0.744106787005019
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,30121,0.0786322055151477,0.049660605837059,-0.018702581925488,0.175966992955783,0.113382654309125
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,52088,0.0224292642382437,0.0529876225390439,-0.0814264759382823,0.12628500441477,0.672085076368241
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,52088,0.021729532010785,0.0766427375064714,-0.128490233501899,0.171949297523469,0.776782501135734
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,52088,-0.141337459068193,0.159111273260118,-0.453195554658024,0.170520636521639,0.374390635656122
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,52088,-0.0972995096272934,0.139129110007068,-0.369992565241147,0.17539354598656,0.484341035864663
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,52088,0.0354997816845617,0.0493374665064557,-0.0612016526680914,0.132201216037215,0.471820451339294
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,52088,0.111227557963703,0.0623410781492255,-0.0109609552087792,0.233416071136185,0.0744055415063628
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,52088,0.0221882350159701,0.025697059671035,-0.0281780019392585,0.0725544719711988,0.387895107200083
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",33633,0.0071812540474464,0.0488313180159079,-0.0885281292637331,0.102890637358626,0.883085748966288
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",33633,-0.0128199921252071,0.0551468269955704,-0.120907773036525,0.0952677887861108,0.816177723066381
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",33633,0.0459075545539769,0.0703842199458806,-0.092045516539949,0.183860625647903,0.514260316014587
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",33633,0.0644345005797583,0.0210819053410001,0.0231139661113981,0.105755035048119,0.002246251331467
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",35815,-0.0426321040492205,0.0234701125993907,-0.0886335247440262,0.00336931664558516,0.0693275920080653
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",35815,0.0062829648897624,0.0189309927396443,-0.0308217808799404,0.0433877106594652,0.739979826655184
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",35815,0.0111707070610194,0.0187429787625399,-0.0255655313135589,0.0479069454355976,0.551190369539605
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",35816,0.00938633722000151,0.0458003618775617,-0.0803823720600195,0.0991550465000225,0.837622303037908
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",35816,0.0231375741844561,0.0298854794705049,-0.0354379655777336,0.0817131139466457,0.438823168473532
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",35816,-0.0351660019979262,0.0372742459580426,-0.10822352407569,0.0378915200798373,0.345475127844824
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,52132,-0.0425679224210722,0.0447908483318301,-0.130357985151459,0.0452221403093147,0.341931908215083
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,52132,-0.0202325294840386,0.029069272037846,-0.0772083026782168,0.0367432437101396,0.486427740308391
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,52132,-0.114634091809347,0.0872139085894981,-0.285573352644763,0.0563051690260693,0.188721790797045
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,52132,-0.0259290834501014,0.0329574896752255,-0.0905257632135434,0.0386675963133406,0.431438758746472
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,52132,-0.0461073531360066,0.0361496808680645,-0.116960727637413,0.0247460213653998,0.202158116082219
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),52132,-0.0402587340759183,0.0398624840206922,-0.118389202756475,0.0378717346046383,0.312532476385688
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,52132,-0.011634771811423,0.0128171462043562,-0.0367563783719613,0.0134868347491152,0.364017754936394
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,28123,-0.0465770557238289,0.0432049656354882,-0.131258788369386,0.038104676921728,0.281073033338397
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,28123,-0.0120740964757526,0.0545891877433237,-0.119068904452667,0.0949207115011618,0.824962019538044
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,28123,0.00986468864960572,0.0401312160468079,-0.0687924948021378,0.0885218721013493,0.805840484868066
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,28123,-0.00836430069415956,0.0332472455873624,-0.0735289020453898,0.0568003006570707,0.801378807088485
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,52270,0.0419765770089857,0.0137331173704518,0.0150596669629002,0.0688934870550712,0.00224074371250778
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,52270,0.0894803938113305,0.0401582279291382,0.0107702670702195,0.168190520552441,0.0258752587437377
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,52270,-0.0175399860620529,0.0138604651768401,-0.0447064978086594,0.00962652568455358,0.205713708567183
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,52270,-0.00779490704733881,0.0134619829753284,-0.0341803936789825,0.0185905795843048,0.562572767396826
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,52270,0.037063283707234,0.0195045156326164,-0.00116556693269421,0.0752921343471621,0.057411590727294
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,52270,0.00377065693092283,0.0200502385546988,-0.0355278106362869,0.0430691244981325,0.850830605543444
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,52270,-0.00488255652234148,0.0148487293241191,-0.0339860659976148,0.0242209529529319,0.74229430390651
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,52270,0.0267953845032221,0.0419559015827462,-0.0554381825989604,0.109028951605405,0.523051949336955
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,43064,-0.030663118256044,0.0146788828392084,-0.0594337286208925,-0.00189250789119552,0.0367274053062046
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,43064,0.029465532759437,0.0154160860336636,-0.000749995866543694,0.0596810613854177,0.0559745144432595
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,43064,0.0215962749930829,0.0184482273704808,-0.0145622506530595,0.0577548006392254,0.241757120278732
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,43065,-0.020546506199275,0.0252913403357151,-0.0701175332572766,0.0290245208587266,0.416576268731085
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,43065,0.00846742508896512,0.0162754849916586,-0.0234325254946858,0.040367375672616,0.60289088312484
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,52027,0.00388103293886057,0.0152184297626851,-0.0259470893960022,0.0337091552737233,0.798708043147844
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,52027,0.00973217178118971,0.0119342625468372,-0.0136589828106113,0.0331233263729907,0.414803575411978
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,52027,0.0199837941764192,0.0142556982558775,-0.00795737440510065,0.047924962757939,0.160982721456952
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,52027,0.00508430053912031,0.0221716292057526,-0.0383720927041547,0.0485406937823954,0.81862529147071
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),52043,0.0268926764336709,0.0130988850948123,0.0012188616478389,0.0525664912195029,0.0400768619674979
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,52043,-0.0155877303664629,0.0179659133003763,-0.0508009204352005,0.0196254597022746,0.385605371620721
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),52132,0.00695124961522725,0.0138235366842161,-0.0201428822858364,0.0340453815162909,0.615069371564447
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,52132,-0.00249927502411363,0.0169970172499488,-0.0358134288340133,0.030814878785786,0.883099935809409
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,52132,0.00462984868724765,0.0255161013444288,-0.0453817099478327,0.054641407322328,0.85601715000662
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,52132,0.0149642931811048,0.0298231918023605,-0.0434891627515217,0.0734177491137313,0.615835343072712
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,52132,0.0368943113242039,0.0293474089511935,-0.0206266102201354,0.0944152328685432,0.20870704324187
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,52132,0.0103857813532694,0.0421784481782052,-0.0722839770760128,0.0930555397825517,0.805502640129604
PLA2G4A,Cytosolic phospholipase A2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",39973,-0.00806857822603763,0.00849066782992395,-0.0247102871726886,0.00857313072061331,0.341980278886454
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X864.Number of days or week walked 10+ minutes,51742,0.00550699776085032,0.0110442775734444,-0.0161397862831007,0.0271537818048014,0.618044662247218
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X874.Duration of walks,48083,-0.00376482088649936,0.00622292528361571,-0.0159617544423861,0.00843211266938743,0.545189886307131
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,51012,0.00676176467455665,0.0107322663097557,-0.0142734772925645,0.0277970066416778,0.528673253119652
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X894.Duration of moderate activity,44884,0.00153700528203229,0.0128458904367942,-0.0236409399740844,0.026714950538149,0.904761892937524
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X90087.No-wear time bias adjusted average acceleration,30348,0.0192201553465155,0.0126173915447908,-0.00550993208127435,0.0439502427743054,0.127730763195434
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,51026,-0.0133556568030239,0.0109720251978583,-0.0348608261908262,0.00814951258477838,0.223521104597118
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X914.Duration of vigorous activity,39904,-0.00621249087238466,0.00798532558805922,-0.0218637290249807,0.0094387472802114,0.436587309688206
